{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Answer Coalescence using only Automat\n",
    "\n",
    "Strider finds and ranks all paths that fulfill the query.  Some of these answers can be very similar.  For instance, two answers may differ only by a gene node, but perhaps those genes are from the same family.  This permits a higher-level, more parsimonious description of an answer set."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "import requests\n",
    "import json\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "from datetime import datetime as dt\n",
    "def query_automat(question,plate):\n",
    "    url = f'https://automat.renci.org/{plate}/reasonerapi'\n",
    "    t0 = dt.now()\n",
    "    r = requests.post(url,json=question)\n",
    "    t1= dt.now()\n",
    "    print(f'It took {t1-t0} s to return')\n",
    "    if r.status_code == 200:\n",
    "        rj = r.json()\n",
    "        #Coming from the KP we don't have a score, but AC expects it, so we're going to dummy it.\n",
    "        for result in rj['results']:\n",
    "            result['score'] = 1\n",
    "        return rj\n",
    "    print(r.status_code)\n",
    "    return None"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "def create_question(disease_curie, relation_type):\n",
    "    question = { \"nodes\": [{\"id\":\"n0\", \"type\":\"disease\", \"curie\":disease_curie},\n",
    "                          {\"id\": \"n1\", \"type\":\"chemical_substance\"}],\n",
    "                 \"edges\": [ {\"id\": \"e0\", \"source_id\": \"n1\", \"target_id\": \"n0\", \"type\": relation_type}]}\n",
    "    return {'query_graph':question}\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "def getlabel(curie):\n",
    "    url = 'https://nodenormalization-sri.renci.org/get_normalized_nodes'\n",
    "    r = requests.get(url,params={'curie':curie}).json()\n",
    "    try:\n",
    "        return r[curie]['id']['label']\n",
    "    except:\n",
    "        return ''"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Property Coalescence\n",
    "\n",
    "Find drugs that treat diabetes in mychem."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "It took 0:00:38.578359 s to return\n"
     ]
    }
   ],
   "source": [
    "#disease = 'MONDO:0005180'  #Parkinson\n",
    "#disease = 'MONDO:0004979'  #Asthma\n",
    "disease = \"MONDO:0005148\"   #T2D\n",
    "edgetype=\"treats\"\n",
    "question = create_question(disease,edgetype)\n",
    "res = query_automat(question,'mychem')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['query_graph', 'results', 'knowledge_graph'])\n",
      "200\n"
     ]
    }
   ],
   "source": [
    "url = 'https://answercoalesce.renci.org/coalesce'\n",
    "params = {'method':'property'}\n",
    "r = requests.post(url,json=res,params=params)\n",
    "print(r.status_code)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "results = r.json()['results']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'qg_id': 'n1', 'kg_id': ['CHEBI:27999', 'CHEBI:71272', 'CHEBI:6801', 'CHEBI:6935', 'CHEBI:31660', 'CHEBI:5383', 'CHEBI:136042', 'CHEBI:135545', 'CHEBI:134731', 'CHEBI:68610', 'CHEBI:136052', 'CHEBI:5384', 'CHEBI:40237', 'CHEBI:32300', 'CHEBI:82720', 'CHEBI:134724', 'CHEBI:135349', 'CHEBI:135285', 'CHEBI:72323', 'CHEBI:9613', 'CHEBI:5441', 'CHEBI:3209', 'CHEBI:3650', 'CHEBI:134735', 'CHEBI:136043', 'CHEBI:93416', 'CHEBI:85078', 'CHEBI:73274', 'CHEBI:9753', 'CHEBI:8805', 'CHEBI:31897', 'CHEBI:8228', 'CHEBI:31654', 'CHEBI:28052', 'CHEBI:135731'], 'coalescence_method': 'property_enrichment', 'p_values': [1.196277654223006e-130], 'properties': ['Blood Glucose Lowering Agents']}\n"
     ]
    }
   ],
   "source": [
    "print(results[0]['node_bindings'][1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "35 [1.196277654223006e-130] ['Blood Glucose Lowering Agents']\n",
      "30 [4.936115949370616e-120] ['Oral Hypoglycemics']\n",
      "31 [7.425481227210775e-120, 1.7111072995800748e-87] ['Drugs Used in Diabetes', 'Alimentary Tract and Metabolism']\n",
      "22 [1.7797817994985986e-67] ['hypoglycemic_agent']\n",
      "25 [4.5954180236113555e-45] ['drugbank.investigational']\n",
      "11 [7.84512571106143e-45] ['Sulfonylureas']\n",
      "26 [3.6061819505761044e-44] ['therapeutic_flag']\n",
      "13 [7.432631862414306e-41] ['Hypoglycemia-Associated Agents']\n",
      "18 [6.9662039084864395e-40] ['Sulfur Compounds']\n",
      "23 [7.279401756016781e-40] ['drugbank.approved']\n",
      "21 [7.356562576276e-40] ['oral']\n",
      "15 [2.6355189664578375e-38] ['Cytochrome P-450 CYP2C9 Substrates']\n",
      "9 [7.541689787649391e-34, 4.659672044972656e-27] ['DPP-IV Inhibitors', 'Agents causing angioedema']\n",
      "12 [5.561853262966284e-32] ['Sulfones']\n",
      "10 [3.7557413407340904e-31] ['Urea']\n",
      "23 [3.889371075810866e-31, 5.329692091072344e-31, 3.3504554405901985e-27] ['drug', 'pharmaceutical', 'application']\n",
      "7 [1.2592754202157175e-28] ['Sulfonylurea Compounds']\n",
      "6 [9.227127269585097e-24, 9.227127269585097e-24] ['insulin_secretagogue', 'secretagogue']\n",
      "12 [2.854184515512469e-23, 2.9978088344295377e-23, 3.3051063591578155e-23] ['Cytochrome P-450 CYP3A4 Substrates (strength unknown)', 'Cytochrome P-450 CYP3A4 Substrates', 'Cytochrome P-450 CYP3A Substrates']\n",
      "11 [9.656932985583232e-23] ['Drugs that are Mainly Renally Excreted']\n",
      "5 [7.517452505826175e-19, 1.6912884279615555e-18, 1.1141118925333053e-10] ['EC_3.4.14.5_(dipeptidyl_peptidase_IV)_inhibitor', 'EC_3.4.14.*_(dipeptidyl__and_tripeptidyl_peptidases)_inhibitor', 'EC_3.4.*_(hydrolases_acting_on_peptide_bond)_inhibitor']\n",
      "13 [1.578344081751395e-18] ['inhibitor']\n",
      "4 [1.3316613031362298e-16, 7.659257932145215e-09, 2.141455304311975e-08] ['Incretins', 'Hormones', 'Hormones, Hormone Substitutes, and Hormone Antagonists']\n",
      "4 [6.657769424661357e-16] ['Sodium-glucose co-transporter 2 (SGLT2) inhibitors']\n",
      "4 [1.997169711949645e-15] ['sodium_glucose_transport_protein_subtype_2_inhibitor']\n",
      "7 [1.1044128113312915e-14] ['Carbohydrates']\n",
      "6 [1.7164063607117065e-14] ['Cytochrome P-450 CYP2C8 Substrates']\n",
      "21 [2.879269639796154e-13] ['biological_role']\n",
      "7 [3.923795793415459e-13] ['Enzyme Inhibitors']\n",
      "3 [5.146888006987433e-12, 3.179224249232599e-08, 1.114818743898265e-06] ['Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors', 'Diuretics', 'Hypotensive Agents']\n",
      "9 [5.5236474567550254e-12] ['enzyme_inhibitor']\n",
      "7 [6.234465292402682e-12] ['EC_3.*_(hydrolase)_inhibitor']\n",
      "4 [9.802735335824685e-12] ['UGT1A9 Substrates']\n",
      "18 [1.6606364063961398e-11] ['biochemical_role']\n",
      "4 [2.1657216139308755e-11] ['Thiazoles']\n",
      "3 [2.5730445526622016e-11, 3.233102482763068e-07] ['Thiazolidinediones', 'OATP1B1/SLCO1B1 Inhibitors']\n",
      "7 [5.1068604124303254e-11] ['natural_product']\n",
      "6 [5.963363619045301e-11] ['Cytochrome P-450 Enzyme Inhibitors']\n",
      "4 [8.971625138365836e-11] ['Protease Inhibitors']\n",
      "3 [1.080427109052861e-10, 2.0794683632591668e-08, 1.4012136750699791e-05, 4.444436158205415e-05] ['EC_2.7.1.33_(pantothenate_kinase)_inhibitor', 'EC_2.7.1.*_(phosphotransferases_with_an_alcohol_group_as_acceptor)_inhibitor', 'EC_2.7.*_(P_containing_group_transferase)_inhibitor', 'EC_2.*_(transferase)_inhibitor']\n",
      "4 [2.552914147488956e-10] ['BSEP/ABCB11 Substrates']\n",
      "4 [4.974606627224127e-10] ['Cycloparaffins']\n",
      "4 [7.622473013433705e-10] ['OAT1/SLC22A6 inhibitors']\n",
      "4 [7.818195240492528e-09] ['Glycosides']\n",
      "42 [8.148510031669367e-09] ['molecule_type:Small molecule']\n",
      "3 [1.0826180776187348e-08] ['UGT2B7 substrates']\n",
      "2 [1.2124081842411131e-08, 7.273419690089431e-08] ['Glinide', 'Potassium Channel Antagonists']\n",
      "2 [1.2124081842411131e-08] ['Sodium-Glucose Transporter 2 Inhibitors']\n",
      "4 [1.2202963023729694e-08] ['drugbank.withdrawn']\n",
      "4 [3.96748439330307e-08] ['P-glycoprotein/ABCB1 Substrates']\n",
      "3 [8.640846462242467e-08, 4.994392117625549e-07] ['Cytochrome P-450 CYP2C19 inhibitors (unknown strength)', 'Cytochrome P-450 CYP2C19 Inhibitors']\n",
      "2 [1.2121508403362967e-07] ['Glycoside Hydrolase Inhibitors']\n",
      "2 [1.8180976072915086e-07, 2.5426366316172516e-06, 6.786227737513792e-06, 8.054667655305387e-06] ['Biguanides', 'Guanidines', 'OCT1 substrates', 'Amidines']\n",
      "3 [7.298902605966993e-07] ['Cytochrome P-450 CYP2C9 Inhibitors']\n",
      "2 [2.070725681728711e-06, 3.6313102271698303e-06] ['potassium_channel_blocker', 'potassium_channel_modulator']\n",
      "2 [3.933641096676327e-06, 3.933641096676327e-06, 2.66833602470947e-05] ['OCT2 Substrates', 'OCT2 substrates with narrow therapeutic index', 'OCT2 Inhibitors']\n",
      "3 [3.999132290643499e-06] ['Cytochrome P-450 CYP2D6 Substrates']\n",
      "3 [5.010753379820441e-06] ['P-glycoprotein/ABCB1 Inhibitors']\n",
      "3 [5.6023346481378445e-06] ['Cytochrome P-450 CYP3A Inhibitors']\n",
      "2 [5.626142092307412e-06] ['Sugar Alcohols']\n",
      "2 [6.000793680926931e-06] ['BSEP/ABCB11 Inhibitors']\n",
      "2 [6.387489750007167e-06] ['UGT1A3 substrates']\n",
      "3 [1.2917452872914876e-05] ['Benzene Derivatives']\n",
      "2 [2.5105943503724745e-05] ['OAT3/SLC22A8 Substrates']\n",
      "2 [2.5888673047794015e-05] ['Piperidines']\n",
      "2 [3.621339400184956e-05] ['UGT1A1 Substrates']\n",
      "3 [5.475102293038813e-05] ['xenobiotic']\n",
      "2 [7.747500044590743e-05] ['Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)']\n",
      "2 [8.021816194755664e-05] ['Cytochrome P-450 CYP1A2 Inhibitors']\n",
      "2 [9.767020463667327e-05] ['Cytochrome P-450 CYP3A4 Inducers (strength unknown)']\n"
     ]
    }
   ],
   "source": [
    "for result in results:\n",
    "    chemnode = result['node_bindings'][1]\n",
    "    print(len(chemnode['kg_id']), chemnode['p_values'], chemnode['properties'])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Ontology Coalescence"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n"
     ]
    }
   ],
   "source": [
    "url = 'https://answercoalesce.renci.org/coalesce'\n",
    "params = {'method':'ontology'}\n",
    "r = requests.post(url,json=res,params=params)\n",
    "print(r.status_code)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3\n"
     ]
    }
   ],
   "source": [
    "results = r.json()['results']\n",
    "print(len(results))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'qg_id': 'n1', 'kg_id': ['CHEBI:5384', 'CHEBI:28052', 'CHEBI:9613', 'CHEBI:5441', 'CHEBI:3650', 'CHEBI:135118', 'CHEBI:5383', 'CHEBI:31654', 'CHEBI:135731', 'CHEBI:27999'], 'coalescence_method': 'ontology_enrichment', 'p_value': 2.7218132323383963e-08, 'superclass': 'CHEBI:35358'}\n"
     ]
    }
   ],
   "source": [
    "print(results[0]['node_bindings'][1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "10 superclass: CHEBI:35358 sulfonamide\n",
      "13 superclass: CHEBI:33261 organosulfur compound\n",
      "8 superclass: CHEBI:76983 N-sulfonylurea\n"
     ]
    }
   ],
   "source": [
    "for result in results:\n",
    "    chemnode = result['node_bindings'][1]\n",
    "    sclass = chemnode['superclass']\n",
    "    label = getlabel(sclass)\n",
    "    print(len(chemnode['kg_id']), 'superclass:',sclass,label)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Graph Coalescence"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n"
     ]
    }
   ],
   "source": [
    "url = 'https://answercoalesce.renci.org/coalesce'\n",
    "params = {'method':'graph'}\n",
    "r = requests.post(url,json=res,params=params)\n",
    "print(r.status_code)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'query_graph': {'nodes': [{'id': 'n0',\n",
       "    'type': 'disease',\n",
       "    'curie': 'MONDO:0005148'},\n",
       "   {'id': 'n1', 'type': 'chemical_substance'}],\n",
       "  'edges': [{'id': 'e0',\n",
       "    'source_id': 'n1',\n",
       "    'target_id': 'n0',\n",
       "    'type': 'treats'}]},\n",
       " 'knowledge_graph': {'nodes': [{'potassium_channel_blocker': True,\n",
       "    'iupac_name': '1-(azepan-1-yl)-3-tosyl-urea',\n",
       "    'pharmaceutical': True,\n",
       "    'role': True,\n",
       "    'inchikey': 'OUDSBRTVNLOZBN-UHFFFAOYSA-N',\n",
       "    'smiles': 'Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1',\n",
       "    'drugbank.accession_number': 'APRD01267',\n",
       "    'mass': '311.40000',\n",
       "    'molecular_weight': 311.4,\n",
       "    'potassium_channel_modulator': True,\n",
       "    'drug': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1',\n",
       "    'chebi.orig_smiles': 'Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CCCCCC1',\n",
       "    'id': 'CHEBI:9613',\n",
       "    'membrane_transport_modulator': True,\n",
       "    'molecular_formula': 'C14H21N3O3S',\n",
       "    'pubchem.orig_smiles': 'CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2',\n",
       "    'charge': '0',\n",
       "    'biophysical_role': True,\n",
       "    'inchi': 'InChI=1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Drugs that are Mainly Renally Excreted',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sulfones',\n",
       "     'Sulfonylurea Compounds',\n",
       "     'Sulfonylureas',\n",
       "     'Sulfur Compounds',\n",
       "     'Urea'],\n",
       "    'synonyms': ['N-(azepan-1-ylcarbamoyl)-4-methylbenzenesulfonamide',\n",
       "     '1-(hexahydro-1-azepinyl)-3-p-tolylsulfonylurea',\n",
       "     '1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea',\n",
       "     '4-(p-tolylsulfonyl)-1,1-hexamethylenesemicarbazide',\n",
       "     'BRN 1323565',\n",
       "     'CCRIS 591',\n",
       "     'Diabewas',\n",
       "     'EINECS 214-588-3',\n",
       "     \"N-(p-toluenesulfonyl)-N'-hexamethyleniminourea\",\n",
       "     'N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide',\n",
       "     'Norglycin',\n",
       "     'tolazamida',\n",
       "     'tolazamide',\n",
       "     'tolazamidum',\n",
       "     'Tolinase',\n",
       "     'U 17835',\n",
       "     'U-17835'],\n",
       "    'equivalent_identifiers': ['INCHIKEY:OUDSBRTVNLOZBN-UHFFFAOYSA-N',\n",
       "     'MESH:D014042',\n",
       "     'CHEBI:9613',\n",
       "     'DRUGBANK:DB00839',\n",
       "     'PUBCHEM:5503',\n",
       "     'UNII:9LT1BRO48Q',\n",
       "     'CHEMBL.COMPOUND:CHEMBL817',\n",
       "     'HMDB:HMDB0014977',\n",
       "     'GTOPDB:6847'],\n",
       "    'application': True,\n",
       "    'name': 'tolazamide',\n",
       "    'drugbank.investigational': True,\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '311.13036',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C22H30N6OS',\n",
       "    'iupac_name': '[(2S,4S)-4-[4-(5-methyl-2-phenyl-pyrazol-3-yl)piperazino]pyrrolidin-2-yl]-thiazolidin-3-yl-methanone',\n",
       "    'pubchem.orig_smiles': 'CC1=NN(C(=C1)N2CCN(CC2)[C@H]3C[C@H](NC3)C(=O)N4CCSC4)C5=CC=CC=C5',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'WGRQANOPCQRCME-PMACEKPBSA-N',\n",
       "    'inchi': 'InChI=1S/C22H30N6OS/c1-17-13-21(28(24-17)18-5-3-2-4-6-18)26-9-7-25(8-10-26)19-14-20(23-15-19)22(29)27-11-12-30-16-27/h2-6,13,19-20,23H,7-12,14-16H2,1H3/t19-,20-/m0/s1',\n",
       "    'drugbank.categories': ['Agents causing angioedema',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'DPP-IV Inhibitors',\n",
       "     'Sulfur Compounds',\n",
       "     'Thiazoles'],\n",
       "    'smiles': 'Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1',\n",
       "    'synonyms': ['tenelia',\n",
       "     'teneligliptin hydrobromide',\n",
       "     'teneligliptin hydrobromide hydrate'],\n",
       "    'mass': '426.580',\n",
       "    'molecular_weight': 426.6,\n",
       "    'equivalent_identifiers': ['UNII:28ZHI4CF9C',\n",
       "     'CHEMBL.COMPOUND:CHEMBL2147777',\n",
       "     'GTOPDB:9906',\n",
       "     'MESH:C579035',\n",
       "     'DRUGBANK:DB11950',\n",
       "     'INCHIKEY:WGRQANOPCQRCME-PMACEKPBSA-N',\n",
       "     'PUBCHEM:11949652',\n",
       "     'CHEBI:136042'],\n",
       "    'simple_smiles': 'Cc1cc(N2CCN(C3CNC(C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1',\n",
       "    'name': 'teneligliptin',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'C1CN(CCN1[C@]2(C[C@](NC2)(C(=O)N3CSCC3)[H])[H])C4=CC(=NN4C5=CC=CC=C5)C',\n",
       "    'monoisotopic_mass': '426.22018',\n",
       "    'id': 'CHEBI:136042',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '1-(4-chlorophenyl)sulfonyl-3-propyl-urea',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'RKWGIWYCVPQPMF-UHFFFAOYSA-N',\n",
       "    'role': True,\n",
       "    'drugbank.accession_number': 'APRD00029',\n",
       "    'smiles': 'CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1',\n",
       "    'mass': '276.74000',\n",
       "    'secretagogue': True,\n",
       "    'molecular_weight': 276.74,\n",
       "    'biochemical_role': True,\n",
       "    'drug': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1',\n",
       "    'chebi.orig_smiles': 'CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1',\n",
       "    'id': 'CHEBI:3650',\n",
       "    'insulin_secretagogue': True,\n",
       "    'molecular_formula': 'C10H13ClN2O3S',\n",
       "    'pubchem.orig_smiles': 'CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Drugs that are Mainly Renally Excreted',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'OAT1/SLC22A6 inhibitors',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sulfones',\n",
       "     'Sulfonylurea Compounds',\n",
       "     'Sulfonylureas',\n",
       "     'Sulfur Compounds',\n",
       "     'Urea'],\n",
       "    'synonyms': ['CHLORPROPAMIDE',\n",
       "     '1-(p-chlorobenzenesulfonyl)-3-propylurea',\n",
       "     '1-(p-chlorophenylsulfonyl)-3-propylurea',\n",
       "     '1-propyl-3-(p-chlorobenzenesulfonyl)urea',\n",
       "     '4-chloro-N-((propylamino)carbonyl)benzenesulfonamide',\n",
       "     '4-chloro-N-[(propylamino)carbonyl]benzenesulfonamide',\n",
       "     'chlorpropamide',\n",
       "     'chlorpropamidum',\n",
       "     'clorpropamida',\n",
       "     \"N-(4-chlorophenylsulfonyl)-N'-propylurea\",\n",
       "     \"N-(p-chlorobenzenesulfonyl)-N'-propylurea\",\n",
       "     \"n-propyl-N'-(p-chlorobenzenesulfonyl)urea\",\n",
       "     \"n-propyl-N'-p-chlorophenylsulfonylcarbamide\"],\n",
       "    'equivalent_identifiers': ['HMDB:HMDB0014810',\n",
       "     'GTOPDB:6801',\n",
       "     'PUBCHEM:2727',\n",
       "     'DRUGBANK:DB00672',\n",
       "     'CHEMBL.COMPOUND:CHEMBL498',\n",
       "     'MESH:D002747',\n",
       "     'INCHIKEY:RKWGIWYCVPQPMF-UHFFFAOYSA-N',\n",
       "     'CHEBI:3650',\n",
       "     'UNII:WTM2C3IL2X'],\n",
       "    'application': True,\n",
       "    'name': 'chlorpropamide',\n",
       "    'drugbank.investigational': True,\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '276.03354',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': 'N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazinamide',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'ZJJXGWJIGJFDTL-UHFFFAOYSA-N',\n",
       "    'role': True,\n",
       "    'drugbank.accession_number': 'APRD00436',\n",
       "    'smiles': 'Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1',\n",
       "    'mass': '445.53500',\n",
       "    'EC_2.7.1.*_(phosphotransferases_with_an_alcohol_group_as_acceptor)_inhibitor': True,\n",
       "    'secretagogue': True,\n",
       "    'molecular_weight': 445.5,\n",
       "    'drug': True,\n",
       "    'biochemical_role': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1',\n",
       "    'chebi.orig_smiles': 'Cc1cnc(cn1)C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1',\n",
       "    'EC_2.*_(transferase)_inhibitor': True,\n",
       "    'id': 'CHEBI:5384',\n",
       "    'insulin_secretagogue': True,\n",
       "    'molecular_formula': 'C21H27N5O4S',\n",
       "    'pubchem.orig_smiles': 'CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'BSEP/ABCB11 Substrates',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Cytochrome P-450 CYP3A Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates (strength unknown)',\n",
       "     'Drugs that are Mainly Renally Excreted',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sulfones',\n",
       "     'Sulfonylurea Compounds',\n",
       "     'Sulfonylureas',\n",
       "     'Sulfur Compounds',\n",
       "     'UGT1A1 Substrates',\n",
       "     'Urea'],\n",
       "    'synonyms': ['N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide',\n",
       "     '1-cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea',\n",
       "     'Aldiab',\n",
       "     'CP 28,720',\n",
       "     'CP 28720',\n",
       "     'CP-28,720',\n",
       "     'Digrin',\n",
       "     'Dipazide',\n",
       "     'Glibenese',\n",
       "     'Glibetin',\n",
       "     'Glican',\n",
       "     'Glidiab',\n",
       "     'Glipid',\n",
       "     'glipizida',\n",
       "     'glipizide',\n",
       "     'glipizidum',\n",
       "     'Gluco-Rite',\n",
       "     'Glucolip',\n",
       "     'Glucotrol',\n",
       "     'Glucozide',\n",
       "     'Glupitel',\n",
       "     'Glupizide',\n",
       "     'Glyde',\n",
       "     'Glydiazinamide',\n",
       "     'K 4024',\n",
       "     'Melizide',\n",
       "     'Mindiab',\n",
       "     'Minidab',\n",
       "     'Minidiab',\n",
       "     'Minodiab',\n",
       "     \"N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-N'-cyclohexylurea\",\n",
       "     'Napizide',\n",
       "     'Ozidia',\n",
       "     'Sucrazide'],\n",
       "    'EC_2.7.1.33_(pantothenate_kinase)_inhibitor': True,\n",
       "    'EC_2.7.*_(P_containing_group_transferase)_inhibitor': True,\n",
       "    'equivalent_identifiers': ['GTOPDB:6821',\n",
       "     'CHEBI:5384',\n",
       "     'INCHIKEY:ZJJXGWJIGJFDTL-UHFFFAOYSA-N',\n",
       "     'HMDB:HMDB0015200',\n",
       "     'UNII:X7WDT95N5C',\n",
       "     'MESH:D005913',\n",
       "     'DRUGBANK:DB01067',\n",
       "     'PUBCHEM:3478',\n",
       "     'CHEMBL.COMPOUND:CHEMBL1073'],\n",
       "    'application': True,\n",
       "    'name': 'glipizide',\n",
       "    'drugbank.investigational': True,\n",
       "    'enzyme_inhibitor': True,\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '445.17838',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '8-[(3R)-3-aminopiperidino]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]xanthine',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'LTXREWYXXSTFRX-QGZVFWFLSA-N',\n",
       "    'role': True,\n",
       "    'smiles': 'CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C',\n",
       "    'mass': '472.54220',\n",
       "    'molecular_weight': 472.5,\n",
       "    'EC_3.4.14.*_(dipeptidyl__and_tripeptidyl_peptidases)_inhibitor': True,\n",
       "    'drug': True,\n",
       "    'biochemical_role': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'CC#CCn1c(N2CCCC(N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C',\n",
       "    'chebi.orig_smiles': 'CC#CCn1c(nc2n(C)c(=O)n(Cc3nc(C)c4ccccc4n3)c(=O)c12)N1CCC[C@@H](N)C1',\n",
       "    'id': 'CHEBI:68610',\n",
       "    'molecular_formula': 'C25H28N8O2',\n",
       "    'pubchem.orig_smiles': 'CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1',\n",
       "    'drugbank.categories': ['Agents causing angioedema',\n",
       "     'Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP3A Inhibitors',\n",
       "     'Cytochrome P-450 CYP3A Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Inhibitors',\n",
       "     'Cytochrome P-450 CYP3A4 Inhibitors (moderate)',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates (strength unknown)',\n",
       "     'Cytochrome P-450 Enzyme Inhibitors',\n",
       "     'DPP-IV Inhibitors',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Enzyme Inhibitors',\n",
       "     'Hormones',\n",
       "     'Hormones, Hormone Substitutes, and Hormone Antagonists',\n",
       "     'Incretins',\n",
       "     'OCT1 inhibitors',\n",
       "     'OCT2 Inhibitors',\n",
       "     'OCT2 Substrates',\n",
       "     'OCT2 substrates with narrow therapeutic index',\n",
       "     'Oral Hypoglycemics',\n",
       "     'P-glycoprotein/ABCB1 Inhibitors',\n",
       "     'P-glycoprotein/ABCB1 Substrates',\n",
       "     'Protease Inhibitors',\n",
       "     'Purines',\n",
       "     'Quinazolines'],\n",
       "    'synonyms': ['8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione',\n",
       "     '(R)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione',\n",
       "     'BI 1356',\n",
       "     'linagliptin',\n",
       "     'Tradjenta'],\n",
       "    'EC_3.*_(hydrolase)_inhibitor': True,\n",
       "    'EC_3.4.14.5_(dipeptidyl_peptidase_IV)_inhibitor': True,\n",
       "    'equivalent_identifiers': ['CHEMBL.COMPOUND:CHEMBL237500',\n",
       "     'GTOPDB:6318',\n",
       "     'INCHIKEY:LTXREWYXXSTFRX-QGZVFWFLSA-N',\n",
       "     'UNII:3X29ZEJ4R2',\n",
       "     'CHEBI:68610',\n",
       "     'DRUGBANK:DB08882',\n",
       "     'MESH:C568794',\n",
       "     'PUBCHEM:10096344'],\n",
       "    'application': True,\n",
       "    'EC_3.4.*_(hydrolases_acting_on_peptide_bond)_inhibitor': True,\n",
       "    'name': 'linagliptin',\n",
       "    'enzyme_inhibitor': True,\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '472.23352',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '(2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-methylol-tetrahydropyran-3,4,5-triol',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'JVHXJTBJCFBINQ-ADAARDCZSA-N',\n",
       "    'role': True,\n",
       "    'smiles': 'CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1',\n",
       "    'mass': '408.87300',\n",
       "    'molecular_weight': 408.9,\n",
       "    'drug': True,\n",
       "    'biochemical_role': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'CCOc1ccc(Cc2cc(C3OC(CO)C(O)C(O)C3O)ccc2Cl)cc1',\n",
       "    'chebi.orig_smiles': 'CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1',\n",
       "    'id': 'CHEBI:85078',\n",
       "    'molecular_formula': 'C21H25ClO6',\n",
       "    'pubchem.orig_smiles': 'CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Benzene Derivatives',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Carbohydrates',\n",
       "     'Cytochrome P-450 CYP1A2 Inhibitors',\n",
       "     'Cytochrome P-450 CYP1A2 Inhibitors (unknown strength)',\n",
       "     'Cytochrome P-450 CYP1A2 Substrates',\n",
       "     'Cytochrome P-450 CYP2A6 Substrates',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Cytochrome P-450 CYP2D6 Substrates',\n",
       "     'Cytochrome P-450 CYP3A Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates (strength unknown)',\n",
       "     'Diuretics',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Glycosides',\n",
       "     'Hypotensive Agents',\n",
       "     'Oral Hypoglycemics',\n",
       "     'P-glycoprotein/ABCB1 Substrates',\n",
       "     'Sodium-glucose co-transporter 2 (SGLT2) inhibitors',\n",
       "     'Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors',\n",
       "     'Sodium-Glucose Transport Proteins, antagonists & inhibitors',\n",
       "     'Sodium-Glucose Transporter 2 Inhibitors',\n",
       "     'UGT1A9 Substrates',\n",
       "     'UGT2B7 substrates'],\n",
       "    'synonyms': ['(1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol',\n",
       "     '(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol',\n",
       "     'BMS 512148',\n",
       "     'BMS-512148',\n",
       "     'dapagliflozin'],\n",
       "    'equivalent_identifiers': ['INCHIKEY:JVHXJTBJCFBINQ-ADAARDCZSA-N',\n",
       "     'CHEMBL.COMPOUND:CHEMBL429910',\n",
       "     'UNII:1ULL0QJ8UC',\n",
       "     'MESH:C529054',\n",
       "     'DRUGBANK:DB06292',\n",
       "     'CHEBI:85078',\n",
       "     'PUBCHEM:9887712',\n",
       "     'GTOPDB:4594'],\n",
       "    'sodium_glucose_transport_protein_subtype_2_inhibitor': True,\n",
       "    'application': True,\n",
       "    'name': 'dapagliflozin',\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '408.13397',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C17H25N3O2',\n",
       "    'iupac_name': '(2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile',\n",
       "    'pubchem.orig_smiles': 'C1C[C@H](N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'SYOKIDBDQMKNDQ-XWTIBIIYSA-N',\n",
       "    'inchi': 'InChI=1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2/t12?,13?,14-,16?,17?/m0/s1',\n",
       "    'drugbank.categories': ['Agents causing angioedema',\n",
       "     'Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cycloparaffins',\n",
       "     'DPP-IV Inhibitors',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Enzyme Inhibitors',\n",
       "     'Glucagon-Like Peptide 1',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Protease Inhibitors'],\n",
       "    'smiles': 'N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2',\n",
       "    'synonyms': ['galvus',\n",
       "     'jalra',\n",
       "     'NVP-LAF237',\n",
       "     'vildagliptin HCl',\n",
       "     'vildagliptin hydrochloride',\n",
       "     'xiliarx'],\n",
       "    'mass': '303.400',\n",
       "    'molecular_weight': 303.4,\n",
       "    'equivalent_identifiers': ['CHEMBL.COMPOUND:CHEMBL142703',\n",
       "     'PUBCHEM:6918537',\n",
       "     'DRUGBANK:DB04876',\n",
       "     'HMDB:HMDB0015596',\n",
       "     'MESH:C502012',\n",
       "     'INCHIKEY:SYOKIDBDQMKNDQ-XWTIBIIYSA-N',\n",
       "     'GTOPDB:6310',\n",
       "     'UNII:I6B4B2U96P',\n",
       "     'CHEBI:135285'],\n",
       "    'simple_smiles': 'N#CC1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2',\n",
       "    'name': 'vildagliptin',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'C1C2CC3(CC1(NCC(N4CCC[C@H]4C#N)=O)CC(C3)C2)O',\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '303.19468',\n",
       "    'id': 'CHEBI:135285',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '3-(diaminomethylene)-1,1-dimethyl-guanidine',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'XZWYZXLIPXDOLR-UHFFFAOYSA-N',\n",
       "    'role': True,\n",
       "    'drugbank.accession_number': 'APRD01099',\n",
       "    'smiles': 'CN(C)C(=N)N=C(N)N',\n",
       "    'mass': '129.16384',\n",
       "    'xenobiotic': True,\n",
       "    'molecular_weight': ['129.1636'],\n",
       "    'drug': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'CN(C)C(=N)N=C(N)N',\n",
       "    'chebi.orig_smiles': 'CN(C)C(=N)NC(N)=N',\n",
       "    'environmental_contaminant': True,\n",
       "    'id': 'CHEBI:6801',\n",
       "    'molecular_formula': ['C4H11N5'],\n",
       "    'pubchem.orig_smiles': 'CN(C)C(=N)N=C(N)N',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Amidines',\n",
       "     'Biguanides',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Drugs that are Mainly Renally Excreted',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Guanidines',\n",
       "     'MATE 1 Substrates',\n",
       "     'MATE 2 Substrates',\n",
       "     'MATE substrates',\n",
       "     'OCT1 substrates',\n",
       "     'OCT2 Inhibitors',\n",
       "     'OCT2 Substrates',\n",
       "     'OCT2 substrates with narrow therapeutic index',\n",
       "     'Oral Hypoglycemics'],\n",
       "    'synonyms': ['Metformin',\n",
       "     'N,N-dimethylimidodicarbonimidic diamide',\n",
       "     '1,1-Dimethylbiguanide'],\n",
       "    'equivalent_identifiers': ['UNII:9100L32L2N',\n",
       "     'KEGG.COMPOUND:C07151',\n",
       "     'DRUGBANK:DB00331',\n",
       "     'HMDB:HMDB0001921',\n",
       "     'INCHIKEY:XZWYZXLIPXDOLR-UHFFFAOYSA-N',\n",
       "     'GTOPDB:4779',\n",
       "     'MESH:D008687',\n",
       "     'CHEBI:6801',\n",
       "     'CHEMBL.COMPOUND:CHEMBL1431',\n",
       "     'PUBCHEM:4091'],\n",
       "    'application': True,\n",
       "    'chemical_role': True,\n",
       "    'name': 'metformin',\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '129.10145',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C18H20FN5O2',\n",
       "    'iupac_name': '2-[[6-[(3R)-3-aminopiperidino]-2,4-diketo-3-methyl-pyrimidin-1-yl]methyl]-4-fluoro-benzonitrile',\n",
       "    'pubchem.orig_smiles': 'CN1C(=O)C=C(N(C1=O)CC2=C(C=CC(=C2)F)C#N)N3CCC[C@H](C3)N',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'IWYJYHUNXVAVAA-OAHLLOKOSA-N',\n",
       "    'inchi': 'InChI=1S/C18H20FN5O2/c1-22-17(25)8-16(23-6-2-3-15(21)11-23)24(18(22)26)10-13-7-14(19)5-4-12(13)9-20/h4-5,7-8,15H,2-3,6,10-11,21H2,1H3/t15-/m1/s1',\n",
       "    'smiles': 'Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O',\n",
       "    'synonyms': ['SYR-472', 'SYR111472', 'trelagliptin succinate', 'zafatek'],\n",
       "    'mass': '357.383',\n",
       "    'molecular_weight': 357.4,\n",
       "    'equivalent_identifiers': ['CHEMBL.COMPOUND:CHEMBL1650443',\n",
       "     'MESH:C000595449',\n",
       "     'INCHIKEY:IWYJYHUNXVAVAA-OAHLLOKOSA-N',\n",
       "     'CHEBI:134715',\n",
       "     'UNII:Q836OWG55H',\n",
       "     'PUBCHEM:15983988'],\n",
       "    'simple_smiles': 'Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2cc(F)ccc2C#N)c1=O',\n",
       "    'name': 'trelagliptin',\n",
       "    'chebi.orig_smiles': 'C1(=CC=C(C=C1CN2C(N(C(C=C2N3CCC[C@H](C3)N)=O)C)=O)F)C#N',\n",
       "    'monoisotopic_mass': '357.16010',\n",
       "    'id': 'CHEBI:134715',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'pharmaceutical': True,\n",
       "    'role': True,\n",
       "    'inchikey': 'WIGIZIANZCJQQY-RUCARUNLSA-N',\n",
       "    'smiles': 'CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O',\n",
       "    'drugbank.accession_number': 'APRD00381',\n",
       "    'mass': '490.61600',\n",
       "    'secretagogue': True,\n",
       "    'biochemical_role': True,\n",
       "    'drug': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCC(C)CC3)cc2)C1=O',\n",
       "    'chebi.orig_smiles': 'CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O',\n",
       "    'id': 'CHEBI:5383',\n",
       "    'insulin_secretagogue': True,\n",
       "    'molecular_formula': 'C24H34N4O5S',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)/t16-,19-',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Antiarrhythmic agents',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'BSEP/ABCB11 Substrates',\n",
       "     'Cardiovascular Agents',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'Immunosuppressive Agents',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sulfones',\n",
       "     'Sulfonylureas',\n",
       "     'Sulfur Compounds'],\n",
       "    'synonyms': ['3-ethyl-4-methyl-N-[2-(4-{[(trans-4-methylcyclohexyl)carbamoyl]sulfamoyl}phenyl)ethyl]-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamide',\n",
       "     '1-((p-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl)phenyl)sulfonyl)-3-(trans-4-methylcyclohexyl)urea',\n",
       "     '1-{[4-(2-{[(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)carbonyl]amino}ethyl)phenyl]sulfonyl}-3-(trans-4-methylcyclohexyl)urea',\n",
       "     'Amaryl',\n",
       "     'gimepiride',\n",
       "     'glimepirida',\n",
       "     'glimepiride',\n",
       "     'glimepiridum'],\n",
       "    'equivalent_identifiers': ['MESH:C057619',\n",
       "     'CHEMBL.COMPOUND:CHEMBL1481',\n",
       "     'INCHIKEY:WIGIZIANZCJQQY-RUCARUNLSA-N',\n",
       "     'CHEBI:5383',\n",
       "     'GTOPDB:6820',\n",
       "     'DRUGBANK:DB00222',\n",
       "     'UNII:6KY687524K'],\n",
       "    'application': True,\n",
       "    'name': 'glimepiride',\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '490.22499',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C23H30O6S',\n",
       "    'iupac_name': '(2S,3R,4R,5S,6R)-2-[5-(4-ethoxybenzyl)-2-methoxy-4-methyl-phenyl]-6-methylol-tetrahydrothiopyran-3,4,5-triol',\n",
       "    'pubchem.orig_smiles': 'CCOC1=CC=C(C=C1)CC2=CC(=C(C=C2C)OC)[C@H]3[C@@H]([C@H]([C@@H]([C@H](S3)CO)O)O)O',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'WHSOLWOTCHFFBK-ZQGJOIPISA-N',\n",
       "    'inchi': 'InChI=1S/C23H30O6S/c1-4-29-16-7-5-14(6-8-16)10-15-11-17(18(28-3)9-13(15)2)23-22(27)21(26)20(25)19(12-24)30-23/h5-9,11,19-27H,4,10,12H2,1-3H3/t19-,20-,21+,22-,23+/m1/s1',\n",
       "    'drugbank.categories': ['Alcohols', 'Carbohydrates', 'Sugar Alcohols'],\n",
       "    'smiles': 'CCOc1ccc(Cc2cc([C@@H]3S[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(OC)cc2C)cc1',\n",
       "    'synonyms': ['lusefi', 'luseogliflozin hydrate', 'TS-071'],\n",
       "    'mass': '434.548',\n",
       "    'molecular_weight': 434.5,\n",
       "    'equivalent_identifiers': ['MESH:C549343',\n",
       "     'UNII:C596HWF74Z',\n",
       "     'DRUGBANK:DB12214',\n",
       "     'INCHIKEY:WHSOLWOTCHFFBK-ZQGJOIPISA-N',\n",
       "     'CHEMBL.COMPOUND:CHEMBL1093423',\n",
       "     'PUBCHEM:11988953',\n",
       "     'CHEBI:134725'],\n",
       "    'simple_smiles': 'CCOc1ccc(Cc2cc(C3SC(CO)C(O)C(O)C3O)c(OC)cc2C)cc1',\n",
       "    'name': 'luseogliflozin',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'C1=CC(=CC=C1CC2=C(C=C(C(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](S3)CO)O)O)O)OC)C)OCC',\n",
       "    'monoisotopic_mass': '434.17631',\n",
       "    'id': 'CHEBI:134725',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': ['C27H36N2O4'],\n",
       "    'iupac_name': '2-ethoxy-4-[2-keto-2-[[(1S)-3-methyl-1-(2-piperidinophenyl)butyl]amino]ethyl]benzoic acid',\n",
       "    'pubchem.orig_smiles': 'CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'FAEKWTJYAYMJKF-QHCPKHFHSA-N',\n",
       "    'inchi': 'InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1',\n",
       "    'drugbank.categories': ['Acids, Acyclic',\n",
       "     'Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'BSEP/ABCB11 Substrates',\n",
       "     'Cytochrome P-450 CYP2C8 Substrates',\n",
       "     'Cytochrome P-450 CYP3A Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates (strength unknown)',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Glinide',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'Meglitinides',\n",
       "     'OATP1B1/SLCO1B1 Substrates',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Potassium Channel Antagonists',\n",
       "     'Stereoisomerism'],\n",
       "    'smiles': 'CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O',\n",
       "    'drugbank.accession_number': 'APRD00439',\n",
       "    'synonyms': ['Repaglinide', '(S)-(+)-Repaglinide', 'enyglid', 'surepost'],\n",
       "    'mass': '452.587',\n",
       "    'molecular_weight': ['452.5857'],\n",
       "    'equivalent_identifiers': ['DRUGBANK:DB00912',\n",
       "     'CHEBI:8805',\n",
       "     'INCHIKEY:FAEKWTJYAYMJKF-QHCPKHFHSA-N',\n",
       "     'CHEMBL.COMPOUND:CHEMBL1272',\n",
       "     'KEGG.COMPOUND:C07670',\n",
       "     'HMDB:HMDB0015048',\n",
       "     'MESH:C072379',\n",
       "     'GTOPDB:6841',\n",
       "     'UNII:668Z8C33LU',\n",
       "     'PUBCHEM:65981'],\n",
       "    'simple_smiles': 'CCOc1cc(CC(=O)NC(CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O',\n",
       "    'name': 'Repaglinide',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(O)=O',\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '452.26751',\n",
       "    'id': 'CHEBI:8805',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '5-[4-[(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl)methoxy]benzyl]thiazolidine-2,4-quinone',\n",
       "    'pharmaceutical': True,\n",
       "    'role': True,\n",
       "    'inchikey': 'GXPHKUHSUJUWKP-UHFFFAOYSA-N',\n",
       "    'smiles': 'Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2',\n",
       "    'drugbank.accession_number': 'APRD00488',\n",
       "    'mass': '441.54000',\n",
       "    'vasodilator_agent': True,\n",
       "    'anticoagulant': True,\n",
       "    'molecular_weight': 441.5,\n",
       "    'drug': True,\n",
       "    'central_nervous_system_drug': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2',\n",
       "    'hematologic_agent': True,\n",
       "    'cardiovascular_drug': True,\n",
       "    'chebi.orig_smiles': 'Cc1c(C)c2OC(C)(CCc2c(C)c1O)COc1ccc(CC2SC(=O)NC2=O)cc1',\n",
       "    'antineoplastic_agent': True,\n",
       "    'id': 'CHEBI:9753',\n",
       "    'molecular_formula': 'C24H27NO5S',\n",
       "    'pubchem.orig_smiles': 'CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C',\n",
       "    'antioxidant': True,\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Benzopyrans',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'BSEP/ABCB11 Inhibitors',\n",
       "     'Chemically-Induced Disorders',\n",
       "     'Cytochrome P-450 CYP2B6 Inducers',\n",
       "     'Cytochrome P-450 CYP2B6 Inducers (strength unknown)',\n",
       "     'Cytochrome P-450 CYP2C19 Inhibitors',\n",
       "     'Cytochrome P-450 CYP2C19 inhibitors (unknown strength)',\n",
       "     'Cytochrome P-450 CYP2C8 Inhibitors',\n",
       "     'Cytochrome P-450 CYP2C8 Inhibitors (strong)',\n",
       "     'Cytochrome P-450 CYP2C8 Substrates',\n",
       "     'Cytochrome P-450 CYP2C9 Inhibitors',\n",
       "     'Cytochrome P-450 CYP2C9 Inhibitors (moderate)',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Cytochrome P-450 CYP3A Inducers',\n",
       "     'Cytochrome P-450 CYP3A Inhibitors',\n",
       "     'Cytochrome P-450 CYP3A4 Inducers',\n",
       "     'Cytochrome P-450 CYP3A4 Inducers (strength unknown)',\n",
       "     'Cytochrome P-450 CYP3A5 Inhibitors',\n",
       "     'Cytochrome P-450 CYP3A5 Inhibitors (strength unknown)',\n",
       "     'Cytochrome P-450 CYP3A7 Inhibitors',\n",
       "     'Cytochrome P-450 CYP3A7 Inhibitors (strength unknown)',\n",
       "     'Cytochrome P-450 Enzyme Inducers',\n",
       "     'Cytochrome P-450 Enzyme Inhibitors',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'OATP1B1/SLCO1B1 Inhibitors',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Peroxisome Proliferator-Activated Receptors, agonists',\n",
       "     'Pyrans',\n",
       "     'Sulfur Compounds',\n",
       "     'Thiazoles',\n",
       "     'Thiazolidinediones',\n",
       "     'UGT1A1 Substrates',\n",
       "     'UGT1A3 substrates',\n",
       "     'UGT1A4 substrates',\n",
       "     'UGT1A6 Inhibitors',\n",
       "     'UGT1A6 substrate',\n",
       "     'UGT1A9 Substrates',\n",
       "     'UGT2B7 substrates'],\n",
       "    'anticonvulsant': True,\n",
       "    'synonyms': ['5-{4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione',\n",
       "     'Troglitazone',\n",
       "     '(+-)-all-rac-5-(p-((6-Hydroxy-2,5,7,8-tetramethyl-2-chromanyl)methoxy)benzyl)-2,4-thiazolidinedione',\n",
       "     '5-(4-(6-Hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl)thiazolidine-2,4-dione',\n",
       "     'Rezulin (TN)',\n",
       "     'Romglizone',\n",
       "     'troglitazona',\n",
       "     'troglitazone',\n",
       "     'troglitazonum'],\n",
       "    'platelet_aggregation_inhibitor': True,\n",
       "    'equivalent_identifiers': ['CHEMBL.COMPOUND:CHEMBL408',\n",
       "     'GTOPDB:2693',\n",
       "     'INCHIKEY:GXPHKUHSUJUWKP-UHFFFAOYSA-N',\n",
       "     'UNII:I66ZZ0ZN0E',\n",
       "     'DRUGBANK:DB00197',\n",
       "     'PUBCHEM:5591',\n",
       "     'CHEBI:9753',\n",
       "     'MESH:C057693'],\n",
       "    'application': True,\n",
       "    'central_nervous_system_depressant': True,\n",
       "    'chemical_role': True,\n",
       "    'drugbank.withdrawn': True,\n",
       "    'name': 'troglitazone',\n",
       "    'drugbank.investigational': True,\n",
       "    'monoisotopic_mass': '441.16099',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methyl-phenyl]-6-methylol-tetrahydropyran-3,4,5-triol',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'XTNGUQKDFGDXSJ-ZXGKGEBGSA-N',\n",
       "    'role': True,\n",
       "    'smiles': 'Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1',\n",
       "    'mass': '444.518',\n",
       "    'molecular_weight': 444.5,\n",
       "    'drug': True,\n",
       "    'biochemical_role': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'Cc1ccc(C2OC(CO)C(O)C(O)C2O)cc1Cc1ccc(-c2ccc(F)cc2)s1',\n",
       "    'chebi.orig_smiles': '[C@@H]1([C@@H]([C@H]([C@@](O[C@@H]1CO)(C2=CC=C(C(=C2)CC=3SC(=CC3)C4=CC=C(C=C4)F)C)[H])O)O)O',\n",
       "    'id': 'CHEBI:73274',\n",
       "    'molecular_formula': 'C24H25FO5S',\n",
       "    'pubchem.orig_smiles': 'CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1',\n",
       "    'drugbank.categories': ['Agents causing hyperkalemia',\n",
       "     'Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP3A Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates (strength unknown)',\n",
       "     'Diuretics',\n",
       "     'Drugs that are Mainly Renally Excreted',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Glucosides',\n",
       "     'Hypotensive Agents',\n",
       "     'Oral Hypoglycemics',\n",
       "     'P-glycoprotein/ABCB1 Inhibitors',\n",
       "     'P-glycoprotein/ABCB1 Substrates',\n",
       "     'Sodium-glucose co-transporter 2 (SGLT2) inhibitors',\n",
       "     'Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors',\n",
       "     'Sulfur Compounds',\n",
       "     'Thiophenes',\n",
       "     'UGT1A9 Substrates'],\n",
       "    'synonyms': ['(1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol',\n",
       "     '1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene'],\n",
       "    'equivalent_identifiers': ['CHEBI:73274',\n",
       "     'DRUGBANK:DB08907',\n",
       "     'INCHIKEY:XTNGUQKDFGDXSJ-ZXGKGEBGSA-N',\n",
       "     'CHEMBL.COMPOUND:CHEMBL2048484',\n",
       "     'GTOPDB:4582',\n",
       "     'PUBCHEM:24812758',\n",
       "     'UNII:6S49DGR869'],\n",
       "    'sodium_glucose_transport_protein_subtype_2_inhibitor': True,\n",
       "    'application': True,\n",
       "    'name': 'canagliflozin',\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '444.14067',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C18H26N2O4S',\n",
       "    'iupac_name': '1-[(1S,2S,3R,4R)-3-hydroxy-4,7,7-trimethyl-norbornan-2-yl]-3-tosyl-urea',\n",
       "    'pubchem.orig_smiles': 'CC1=CC=C(C=C1)S(=O)(=O)NC(=O)N[C@H]2[C@H]3CC[C@@]([C@H]2O)(C3(C)C)C',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'RMTYNAPTNBJHQI-LLDVTBCESA-N',\n",
       "    'inchi': 'InChI=1S/C18H26N2O4S/c1-11-5-7-12(8-6-11)25(23,24)20-16(22)19-14-13-9-10-18(4,15(14)21)17(13,2)3/h5-8,13-15,21H,9-10H2,1-4H3,(H2,19,20,22)/t13-,14+,15+,18+/m1/s1',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sulfones',\n",
       "     'Sulfonylureas',\n",
       "     'Sulfur Compounds',\n",
       "     'Urea'],\n",
       "    'smiles': 'Cc1ccc(S(=O)(=O)NC(=O)N[C@H]2[C@H]3CC[C@@](C)([C@H]2O)C3(C)C)cc1',\n",
       "    'synonyms': ['glibornurid', 'gluboride', 'Ro-6-4563'],\n",
       "    'mass': '366.477',\n",
       "    'molecular_weight': 366.5,\n",
       "    'equivalent_identifiers': ['DRUGBANK:DB08962',\n",
       "     'UNII:VP83E7434R',\n",
       "     'CHEMBL.COMPOUND:CHEMBL529888',\n",
       "     'INCHIKEY:RMTYNAPTNBJHQI-LLDVTBCESA-N',\n",
       "     'PUBCHEM:12818200',\n",
       "     'MESH:C073323',\n",
       "     'CHEBI:135545'],\n",
       "    'simple_smiles': 'Cc1ccc(S(=O)(=O)NC(=O)NC2C3CCC(C)(C2O)C3(C)C)cc1',\n",
       "    'drugbank.withdrawn': True,\n",
       "    'name': 'glibornuride',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'C[C@@]12C(C)(C)[C@@H]([C@@H]([C@@H]1O)NC(NS(=O)(=O)C3=CC=C(C=C3)C)=O)CC2',\n",
       "    'monoisotopic_mass': '366.16133',\n",
       "    'id': 'CHEBI:135545',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '(3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-methylol-cyclohex-2-en-1-yl]amino]tetrahydropyran-2-yl]oxy-3,4-dihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-6-methylol-tetrahydropyran-2,3,4-triol',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'XUFXOAAUWZOOIT-UGEKTDRHSA-N',\n",
       "    'role': True,\n",
       "    'smiles': 'C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)OC(O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O',\n",
       "    'mass': '645.60480',\n",
       "    'molecular_weight': ['645.6048'],\n",
       "    'drug': True,\n",
       "    'biochemical_role': True,\n",
       "    'EC_3.2.1.*_(glycosidase)_inhibitor': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'CC1OC(OC2C(CO)OC(OC3C(CO)OC(O)C(O)C3O)C(O)C2O)C(O)C(O)C1NC1C=C(CO)C(O)C(O)C1O',\n",
       "    'chebi.orig_smiles': 'C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)OC(O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O',\n",
       "    'id': 'CHEBI:2376',\n",
       "    'molecular_formula': ['C25H43NO18'],\n",
       "    'EC_3.2.*_(glycosylase)_inhibitor': True,\n",
       "    'pubchem.orig_smiles': 'C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](OC([C@@H]([C@H]3O)O)O)CO)CO)O)O)N[C@H]4C=C([C@H]([C@@H]([C@H]4O)O)O)CO',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C25H43NO18/c1-6-11(26-8-2-7(3-27)12(30)15(33)13(8)31)14(32)19(37)24(40-6)43-22-10(5-29)42-25(20(38)17(22)35)44-21-9(4-28)41-23(39)18(36)16(21)34/h2,6,8-39H,3-5H2,1H3/t6-,8+,9-,10-,11-,12-,13+,14+,15+,16-,17-,18-,19-,20-,21-,22-,23?,24-,25-/m1/s1',\n",
       "    'synonyms': ['4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-D-glucopyranose',\n",
       "     'Acarbose',\n",
       "     'acarbosa',\n",
       "     'acarbose',\n",
       "     'acarbosum',\n",
       "     'Glucobay',\n",
       "     'Precose'],\n",
       "    'EC_3.*_(hydrolase)_inhibitor': True,\n",
       "    'EC_3.2.1.20_(alpha_glucosidase)_inhibitor': True,\n",
       "    'equivalent_identifiers': ['CHEBI:2376',\n",
       "     'KEGG.COMPOUND:C06802',\n",
       "     'INCHIKEY:XUFXOAAUWZOOIT-UGEKTDRHSA-N',\n",
       "     'CHEMBL.COMPOUND:CHEMBL404271',\n",
       "     'PUBCHEM:41774'],\n",
       "    'application': True,\n",
       "    'EC_3.2.1.1_(alpha_amylase)_inhibitor': True,\n",
       "    'name': 'acarbose',\n",
       "    'enzyme_inhibitor': True,\n",
       "    'monoisotopic_mass': '645.24801',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C24H24N4O5S',\n",
       "    'iupac_name': '5-[4-[2-[[6-(4-methoxyphenoxy)pyrimidin-4-yl]-methyl-amino]ethoxy]benzyl]thiazolidine-2,4-quinone',\n",
       "    'pubchem.orig_smiles': 'CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC(=NC=N3)OC4=CC=C(C=C4)OC',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'CHHXEZSCHQVSRE-UHFFFAOYSA-N',\n",
       "    'inchi': 'InChI=1S/C24H24N4O5S/c1-28(21-14-22(26-15-25-21)33-19-9-7-17(31-2)8-10-19)11-12-32-18-5-3-16(4-6-18)13-20-23(29)27-24(30)34-20/h3-10,14-15,20H,11-13H2,1-2H3,(H,27,29,30)',\n",
       "    'drugbank.categories': ['Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP1A2 Inhibitors',\n",
       "     'Cytochrome P-450 CYP1A2 Inhibitors (moderate)',\n",
       "     'Cytochrome P-450 CYP2C19 Inhibitors',\n",
       "     'Cytochrome P-450 CYP2C19 inhibitors (unknown strength)',\n",
       "     'Cytochrome P-450 CYP2C8 Substrates',\n",
       "     'Cytochrome P-450 CYP2C9 Inhibitors',\n",
       "     'Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)',\n",
       "     'Cytochrome P-450 CYP3A Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates (strength unknown)',\n",
       "     'Cytochrome P-450 Enzyme Inhibitors',\n",
       "     'OATP1B1/SLCO1B1 Inhibitors',\n",
       "     'PPAR alpha, agonists',\n",
       "     'PPAR gamma, agonists',\n",
       "     'Sulfur Compounds',\n",
       "     'Thiazoles',\n",
       "     'Thiazolidinediones'],\n",
       "    'smiles': 'COc1ccc(Oc2cc(N(C)CCOc3ccc(CC4SC(=O)NC4=O)cc3)ncn2)cc1',\n",
       "    'synonyms': ['CKD-501', 'duvie', 'lobeglitazone sulfate'],\n",
       "    'mass': '480.538',\n",
       "    'molecular_weight': 480.5,\n",
       "    'drugbank.experimental': True,\n",
       "    'equivalent_identifiers': ['DRUGBANK:DB09198',\n",
       "     'INCHIKEY:CHHXEZSCHQVSRE-UHFFFAOYSA-N',\n",
       "     'CHEBI:136052',\n",
       "     'CHEMBL.COMPOUND:CHEMBL3585580',\n",
       "     'PUBCHEM:9826451'],\n",
       "    'simple_smiles': 'COc1ccc(Oc2cc(N(C)CCOc3ccc(CC4SC(=O)NC4=O)cc3)ncn2)cc1',\n",
       "    'name': 'lobeglitazone',\n",
       "    'chebi.orig_smiles': 'C1=C(C=CC(=C1)OC2=CC(=NC=N2)N(CCOC3=CC=C(C=C3)CC4(C(NC(S4)=O)=O)[H])C)OC',\n",
       "    'monoisotopic_mass': '480.14674',\n",
       "    'id': 'CHEBI:136052',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C21H21FO5S',\n",
       "    'iupac_name': '(2S,3R,4R,5S,6R)-2-[3-(benzothiophen-2-ylmethyl)-4-fluoro-phenyl]-6-methylol-tetrahydropyran-3,4,5-triol',\n",
       "    'pubchem.orig_smiles': 'C1=CC=C2C(=C1)C=C(S2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)F',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'AHFWIQIYAXSLBA-RQXATKFSSA-N',\n",
       "    'inchi': 'InChI=1S/C21H21FO5S/c22-15-6-5-12(21-20(26)19(25)18(24)16(10-23)27-21)7-13(15)9-14-8-11-3-1-2-4-17(11)28-14/h1-8,16,18-21,23-26H,9-10H2/t16-,18-,19+,20-,21+/m1/s1',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Carbohydrates',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Glycosides',\n",
       "     'Sodium-glucose co-transporter 2 (SGLT2) inhibitors',\n",
       "     'Sulfur Compounds'],\n",
       "    'smiles': 'OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O',\n",
       "    'synonyms': ['ASP1941', 'ipragliflozin L-proline', 'suglat'],\n",
       "    'mass': '404.454',\n",
       "    'molecular_weight': 404.5,\n",
       "    'equivalent_identifiers': ['UNII:3N2N8OOR7X',\n",
       "     'MESH:C572941',\n",
       "     'INCHIKEY:AHFWIQIYAXSLBA-RQXATKFSSA-N',\n",
       "     'CHEMBL.COMPOUND:CHEMBL2018096',\n",
       "     'GTOPDB:9394',\n",
       "     'CHEBI:134724',\n",
       "     'PUBCHEM:10453870',\n",
       "     'DRUGBANK:DB11698'],\n",
       "    'simple_smiles': 'OCC1OC(c2ccc(F)c(Cc3cc4ccccc4s3)c2)C(O)C(O)C1O',\n",
       "    'name': 'ipragliflozin',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'C1=CC=CC2=C1C=C(S2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)F',\n",
       "    'monoisotopic_mass': '404.10937',\n",
       "    'id': 'CHEBI:134724',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'potassium_channel_blocker': True,\n",
       "    'iupac_name': '1-butyl-3-tosyl-urea',\n",
       "    'pharmaceutical': True,\n",
       "    'role': True,\n",
       "    'inchikey': 'JLRGJRBPOGGCBT-UHFFFAOYSA-N',\n",
       "    'smiles': 'CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1',\n",
       "    'drugbank.accession_number': 'APRD00267',\n",
       "    'mass': '270.34800',\n",
       "    'secretagogue': True,\n",
       "    'mammalian_metabolite': True,\n",
       "    'molecular_weight': ['270.3479'],\n",
       "    'potassium_channel_modulator': True,\n",
       "    'biochemical_role': True,\n",
       "    'drug': True,\n",
       "    'metabolite': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1',\n",
       "    'chebi.orig_smiles': 'CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1',\n",
       "    'id': 'CHEBI:27999',\n",
       "    'insulin_secretagogue': True,\n",
       "    'membrane_transport_modulator': True,\n",
       "    'molecular_formula': ['C12H18N2O3S'],\n",
       "    'pubchem.orig_smiles': 'CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C',\n",
       "    'animal_metabolite': True,\n",
       "    'charge': '0',\n",
       "    'biophysical_role': True,\n",
       "    'inchi': 'InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP2C18 Substrates',\n",
       "     'Cytochrome P-450 CYP2C8 Substrates',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Diagnostic Agents',\n",
       "     'Drugs that are Mainly Renally Excreted',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'OAT1/SLC22A6 inhibitors',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sulfones',\n",
       "     'Sulfonylurea Compounds',\n",
       "     'Sulfonylureas',\n",
       "     'Sulfur Compounds',\n",
       "     'Tests for Diabetes',\n",
       "     'Urea'],\n",
       "    'synonyms': ['N-[(butylamino)carbonyl]-4-methylbenzenesulfonamide',\n",
       "     'Tolbutamide',\n",
       "     '1-Butyl-3-(p-methylphenylsulfonyl)urea',\n",
       "     '1-Butyl-3-(p-tolylsulfonyl)urea',\n",
       "     '1-Butyl-3-tosylurea',\n",
       "     '1-p-Toluenesulfonyl-3-butylurea',\n",
       "     '3-(p-Tolyl-4-sulfonyl)-1-butylurea',\n",
       "     \"N-(4-Methylbenzenesulfonyl)-N'-butylurea\",\n",
       "     \"N-(4-Methylphenylsulfonyl)-N'-butylurea\",\n",
       "     \"N-(p-Methylbenzenesulfonyl)-N'-butylurea\",\n",
       "     \"N-(Sulfonyl-p-methylbenzene)-N'-N-butylurea\",\n",
       "     \"N-Butyl-N'-(4-methylphenylsulfonyl)urea\",\n",
       "     \"N-Butyl-N'-(p-tolylsulfonyl)urea\",\n",
       "     \"N-Butyl-N'-p-toluenesulfonylurea\",\n",
       "     \"N-n-Butyl-N'-tosylurea\",\n",
       "     'Orinase (TN)',\n",
       "     'tolbutamida',\n",
       "     'tolbutamide',\n",
       "     'tolbutamidum',\n",
       "     'Tolylsulfonylbutylurea'],\n",
       "    'equivalent_identifiers': ['MESH:D014044',\n",
       "     'CHEBI:27999',\n",
       "     'UNII:982XCM1FOI',\n",
       "     'DRUGBANK:DB01124',\n",
       "     'INCHIKEY:JLRGJRBPOGGCBT-UHFFFAOYSA-N',\n",
       "     'PUBCHEM:5505',\n",
       "     'KEGG.COMPOUND:C07148',\n",
       "     'GTOPDB:6848',\n",
       "     'CHEMBL.COMPOUND:CHEMBL782',\n",
       "     'HMDB:HMDB0015256'],\n",
       "    'application': True,\n",
       "    'human_metabolite': True,\n",
       "    'name': 'tolbutamide',\n",
       "    'drugbank.investigational': True,\n",
       "    'eukaryotic_metabolite': True,\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '270.10381',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '2-[[6-[(3R)-3-aminopiperidino]-2,4-diketo-3-methyl-pyrimidin-1-yl]methyl]benzonitrile',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'ZSBOMTDTBDDKMP-OAHLLOKOSA-N',\n",
       "    'role': True,\n",
       "    'Bronsted_base': True,\n",
       "    'smiles': 'Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O',\n",
       "    'mass': '339.39160',\n",
       "    'molecular_weight': 339.4,\n",
       "    'EC_3.4.14.*_(dipeptidyl__and_tripeptidyl_peptidases)_inhibitor': True,\n",
       "    'drug': True,\n",
       "    'biochemical_role': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'Cn1c(=O)cc(N2CCCC(N)C2)n(Cc2ccccc2C#N)c1=O',\n",
       "    'chebi.orig_smiles': 'Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O',\n",
       "    'id': 'CHEBI:72323',\n",
       "    'molecular_formula': 'C18H21N5O2',\n",
       "    'pubchem.orig_smiles': 'CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)N',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C18H21N5O2/c1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19/h2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3/t15-/m1/s1',\n",
       "    'acceptor': True,\n",
       "    'drugbank.categories': ['Agents causing angioedema',\n",
       "     'Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP2D6 Substrates',\n",
       "     'Cytochrome P-450 CYP3A Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates (strength unknown)',\n",
       "     'DPP-IV Inhibitors',\n",
       "     'Drugs that are Mainly Renally Excreted',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Enzyme Inhibitors',\n",
       "     'Hormones',\n",
       "     'Hormones, Hormone Substitutes, and Hormone Antagonists',\n",
       "     'Incretins',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Pyrimidines',\n",
       "     'Pyrimidinones'],\n",
       "    'synonyms': ['2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)benzonitrile',\n",
       "     'alogliptin',\n",
       "     'alogliptina',\n",
       "     'alogliptine',\n",
       "     'alogliptinum'],\n",
       "    'EC_3.*_(hydrolase)_inhibitor': True,\n",
       "    'EC_3.4.14.5_(dipeptidyl_peptidase_IV)_inhibitor': True,\n",
       "    'equivalent_identifiers': ['CHEBI:72323',\n",
       "     'DRUGBANK:DB06203',\n",
       "     'GTOPDB:6319',\n",
       "     'MESH:C520853',\n",
       "     'INCHIKEY:ZSBOMTDTBDDKMP-OAHLLOKOSA-N',\n",
       "     'UNII:JHC049LO86',\n",
       "     'CHEMBL.COMPOUND:CHEMBL376359',\n",
       "     'PUBCHEM:11450633'],\n",
       "    'application': True,\n",
       "    'chemical_role': True,\n",
       "    'EC_3.4.*_(hydrolases_acting_on_peptide_bond)_inhibitor': True,\n",
       "    'name': 'alogliptin',\n",
       "    'enzyme_inhibitor': True,\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '339.16952',\n",
       "    'base': True,\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': ['C8H17NO5'],\n",
       "    'iupac_name': '(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-methylol-piperidine-3,4,5-triol',\n",
       "    'pubchem.orig_smiles': 'C1[C@@H]([C@H]([C@@H]([C@H](N1CCO)CO)O)O)O',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'IBAQFPQHRJAVAV-ULAWRXDQSA-N',\n",
       "    'inchi': 'InChI=1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/t5-,6+,7-,8-/m1/s1',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Alkaloids',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Carbohydrates',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Enzyme Inhibitors',\n",
       "     'Glycoside Hydrolase Inhibitors',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'Imines',\n",
       "     'Imino Pyranoses',\n",
       "     'Imino Sugars',\n",
       "     'Monosaccharides',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Piperidines'],\n",
       "    'smiles': 'OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO',\n",
       "    'drugbank.accession_number': 'APRD01117',\n",
       "    'synonyms': ['Miglitol', 'diastabol', 'glyset', 'seibule'],\n",
       "    'mass': '207.225',\n",
       "    'molecular_weight': ['207.2243'],\n",
       "    'equivalent_identifiers': ['CHEBI:6935',\n",
       "     'HMDB:HMDB0014634',\n",
       "     'KEGG.COMPOUND:C07708',\n",
       "     'UNII:0V5436JAQW',\n",
       "     'MESH:C045621',\n",
       "     'PUBCHEM:441314',\n",
       "     'GTOPDB:4842',\n",
       "     'INCHIKEY:IBAQFPQHRJAVAV-ULAWRXDQSA-N',\n",
       "     'CHEMBL.COMPOUND:CHEMBL1561',\n",
       "     'DRUGBANK:DB00491'],\n",
       "    'simple_smiles': 'OCCN1CC(O)C(O)C(O)C1CO',\n",
       "    'name': 'Miglitol',\n",
       "    'chebi.orig_smiles': 'OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO',\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '207.11067',\n",
       "    'id': 'CHEBI:6935',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'MFFMDFFZMYYVKS-SECBINFHSA-N',\n",
       "    'role': True,\n",
       "    'drugbank.accession_number': 'DB07214',\n",
       "    'smiles': 'N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F',\n",
       "    'mass': '407.31382',\n",
       "    'xenobiotic': True,\n",
       "    'molecular_weight': 407.31,\n",
       "    'EC_3.4.14.*_(dipeptidyl__and_tripeptidyl_peptidases)_inhibitor': True,\n",
       "    'biochemical_role': True,\n",
       "    'drug': True,\n",
       "    'protease_inhibitor': True,\n",
       "    'serine_proteinase_inhibitor': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'NC(CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F',\n",
       "    'chebi.orig_smiles': 'N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc1cc(F)c(F)cc1F',\n",
       "    'environmental_contaminant': True,\n",
       "    'id': 'CHEBI:40237',\n",
       "    'molecular_formula': 'C16H15F6N5O',\n",
       "    'pubchem.orig_smiles': 'C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1',\n",
       "    'drugbank.categories': ['Agents causing angioedema',\n",
       "     'Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP2C8 Substrates',\n",
       "     'Cytochrome P-450 CYP3A Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates (strength unknown)',\n",
       "     'DPP-IV Inhibitors',\n",
       "     'Drugs that are Mainly Renally Excreted',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Enzyme Inhibitors',\n",
       "     'Hormones',\n",
       "     'Hormones, Hormone Substitutes, and Hormone Antagonists',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'Incretins',\n",
       "     'OAT3/SLC22A8 Substrates',\n",
       "     'Oral Hypoglycemics',\n",
       "     'P-glycoprotein/ABCB1 Substrates',\n",
       "     'Protease Inhibitors',\n",
       "     'Triazoles'],\n",
       "    'synonyms': ['(3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one',\n",
       "     '(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE',\n",
       "     'MK-0431',\n",
       "     'sitagliptin',\n",
       "     'sitagliptina',\n",
       "     'sitagliptine',\n",
       "     'sitagliptinum'],\n",
       "    'EC_3.*_(hydrolase)_inhibitor': True,\n",
       "    'EC_3.4.14.5_(dipeptidyl_peptidase_IV)_inhibitor': True,\n",
       "    'equivalent_identifiers': ['MESH:C496398',\n",
       "     'CHEBI:40237',\n",
       "     'UNII:QFP0P1DV7Z',\n",
       "     'INCHIKEY:MFFMDFFZMYYVKS-SECBINFHSA-N',\n",
       "     'DRUGBANK:DB01261',\n",
       "     'HMDB:HMDB0015390',\n",
       "     'PUBCHEM:4369359',\n",
       "     'CHEMBL.COMPOUND:CHEMBL1422',\n",
       "     'GTOPDB:6286'],\n",
       "    'application': True,\n",
       "    'chemical_role': True,\n",
       "    'EC_3.4.*_(hydrolases_acting_on_peptide_bond)_inhibitor': True,\n",
       "    'name': 'sitagliptin',\n",
       "    'drugbank.investigational': True,\n",
       "    'enzyme_inhibitor': True,\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '407.11808',\n",
       "    'EC_3.4.21.*_(serine_endopeptidase)_inhibitor': True,\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C19H25NO3',\n",
       "    'iupac_name': '(2S)-4-[(3aR,7aS)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-keto-butyric acid',\n",
       "    'pubchem.orig_smiles': 'C1CC[C@H]2CN(C[C@H]2C1)C(=O)C[C@H](CC3=CC=CC=C3)C(=O)O',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'WPGGHFDDFPHPOB-BBWFWOEESA-N',\n",
       "    'role': True,\n",
       "    'inchi': 'InChI=1S/C19H25NO3/c21-18(20-12-15-8-4-5-9-16(15)13-20)11-17(19(22)23)10-14-6-2-1-3-7-14/h1-3,6-7,15-17H,4-5,8-13H2,(H,22,23)/t15-,16+,17-/m0/s1',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Oral Hypoglycemics',\n",
       "     'UGT1A3 substrates',\n",
       "     'UGT2B7 substrates'],\n",
       "    'smiles': 'O=C(O)[C@H](CC(=O)N1C[C@H]2CCCC[C@H]2C1)Cc1ccccc1',\n",
       "    'synonyms': ['KAD-1229',\n",
       "     'mitiglinide calcium',\n",
       "     'mitiglinide calcium hydrate',\n",
       "     'S 21403'],\n",
       "    'mass': '315.407',\n",
       "    'molecular_weight': 315.4,\n",
       "    'Bronsted_acid': True,\n",
       "    'equivalent_identifiers': ['CHEBI:135349',\n",
       "     'UNII:D86I0XLB13',\n",
       "     'MESH:C087255',\n",
       "     'INCHIKEY:WPGGHFDDFPHPOB-BBWFWOEESA-N',\n",
       "     'CHEMBL.COMPOUND:CHEMBL471498',\n",
       "     'PUBCHEM:121891',\n",
       "     'DRUGBANK:DB01252'],\n",
       "    'acid': True,\n",
       "    'donor': True,\n",
       "    'simple_smiles': 'O=C(O)C(CC(=O)N1CC2CCCCC2C1)Cc1ccccc1',\n",
       "    'chemical_role': True,\n",
       "    'name': 'mitiglinide',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'C(C[C@H](CC1=CC=CC=C1)C(O)=O)(=O)N2C[C@]3([C@@](C2)(CCCC3)[H])[H]',\n",
       "    'monoisotopic_mass': '315.18344',\n",
       "    'id': 'CHEBI:135349',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '5-[4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-quinone',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'HYAFETHFCAUJAY-UHFFFAOYSA-N',\n",
       "    'role': True,\n",
       "    'drugbank.accession_number': 'APRD00653',\n",
       "    'smiles': 'CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1',\n",
       "    'mass': '356.43978',\n",
       "    'EC_2.7.1.*_(phosphotransferases_with_an_alcohol_group_as_acceptor)_inhibitor': True,\n",
       "    'xenobiotic': True,\n",
       "    'molecular_weight': ['356.4387'],\n",
       "    'drug': True,\n",
       "    'biochemical_role': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1',\n",
       "    'chebi.orig_smiles': 'CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1',\n",
       "    'EC_2.*_(transferase)_inhibitor': True,\n",
       "    'id': 'CHEBI:8228',\n",
       "    'pharmacological_role': True,\n",
       "    'molecular_formula': ['C19H20N2O3S'],\n",
       "    'pubchem.orig_smiles': 'CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP2C8 Inhibitors',\n",
       "     'Cytochrome P-450 CYP2C8 Inhibitors (moderate)',\n",
       "     'Cytochrome P-450 CYP2C8 Substrates',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Cytochrome P-450 CYP3A Inducers',\n",
       "     'Cytochrome P-450 CYP3A Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Inducers',\n",
       "     'Cytochrome P-450 CYP3A4 Inducers (strength unknown)',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates (strength unknown)',\n",
       "     'Cytochrome P-450 Enzyme Inducers',\n",
       "     'Cytochrome P-450 Enzyme Inhibitors',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'OATP1B1/SLCO1B1 Inhibitors',\n",
       "     'OATP1B3 inhibitors',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Peroxisome Proliferator Receptor alpha Agonist',\n",
       "     'Peroxisome Proliferator Receptor gamma Agonist',\n",
       "     'Peroxisome Proliferator-activated Receptor Activity',\n",
       "     'Sulfur Compounds',\n",
       "     'Thiazoles',\n",
       "     'Thiazolidinediones'],\n",
       "    'synonyms': ['5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione',\n",
       "     'Pioglitazone',\n",
       "     '(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione',\n",
       "     'pioglitazona',\n",
       "     'pioglitazone',\n",
       "     'pioglitazonum'],\n",
       "    'EC_2.7.1.33_(pantothenate_kinase)_inhibitor': True,\n",
       "    'agonist': True,\n",
       "    'EC_2.7.*_(P_containing_group_transferase)_inhibitor': True,\n",
       "    'equivalent_identifiers': ['GTOPDB:2694',\n",
       "     'KEGG.COMPOUND:C07675',\n",
       "     'DRUGBANK:DB01132',\n",
       "     'HMDB:HMDB0015264',\n",
       "     'MESH:D000077205',\n",
       "     'UNII:X4OV71U42S',\n",
       "     'INCHIKEY:HYAFETHFCAUJAY-UHFFFAOYSA-N',\n",
       "     'CHEBI:8228',\n",
       "     'PUBCHEM:4829',\n",
       "     'CHEMBL.COMPOUND:CHEMBL595'],\n",
       "    'application': True,\n",
       "    'PPAR_modulator': True,\n",
       "    'name': 'pioglitazone',\n",
       "    'drugbank.investigational': True,\n",
       "    'insulin_sensitizing_drug': True,\n",
       "    'enzyme_inhibitor': True,\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '356.11946',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': ['C6H15N5'],\n",
       "    'iupac_name': '2-butyl-1-(diaminomethylene)guanidine',\n",
       "    'pubchem.orig_smiles': 'CCCCN=C(N)N=C(N)N',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'XSEUMFJMFFMCIU-UHFFFAOYSA-N',\n",
       "    'role': True,\n",
       "    'inchi': 'InChI=1S/C6H15N5/c1-2-3-4-10-6(9)11-5(7)8/h2-4H2,1H3,(H6,7,8,9,10,11)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Amidines',\n",
       "     'Biguanides',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Guanidines',\n",
       "     'OCT1 substrates',\n",
       "     'Oral Hypoglycemics'],\n",
       "    'smiles': 'CCCCN=C(N)N=C(N)N',\n",
       "    'synonyms': ['Buformin',\n",
       "     '1-Butylbiguanide',\n",
       "     'buformin HCl',\n",
       "     'buformin hydrochloride',\n",
       "     'buformine',\n",
       "     'butformin',\n",
       "     'butylbiguanide',\n",
       "     'butyldiguanide'],\n",
       "    'molecular_weight': ['157.2168'],\n",
       "    'equivalent_identifiers': ['MESH:D002026',\n",
       "     'PUBCHEM:2468',\n",
       "     'UNII:W2115E9C7B',\n",
       "     'KEGG.COMPOUND:C07674',\n",
       "     'CHEBI:3209',\n",
       "     'DRUGBANK:DB04830',\n",
       "     'INCHIKEY:XSEUMFJMFFMCIU-UHFFFAOYSA-N',\n",
       "     'CHEMBL.COMPOUND:CHEMBL39736'],\n",
       "    'drug': True,\n",
       "    'application': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'CCCCN=C(N)N=C(N)N',\n",
       "    'drugbank.withdrawn': True,\n",
       "    'name': 'Buformin',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'CCCCNC(=N)NC(N)=N',\n",
       "    'id': 'CHEBI:3209',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'nutritional_or_metabolic_disease': True,\n",
       "    'synonyms': ['NIDDM',\n",
       "     'Non-insulin dependent diabetes',\n",
       "     'Type 2 diabetes',\n",
       "     'Type II diabetes',\n",
       "     'Diabetes mellitus Type II',\n",
       "     'Diabetes mellitus, noninsulin-dependent',\n",
       "     'NIDDM diabetes mellitus',\n",
       "     'Noninsulin dependent diabetes mellitus',\n",
       "     'Noninsulin-dependent diabetes',\n",
       "     'Diabetes mellitus type 2',\n",
       "     'Noninsulin-dependent diabetes mellitus',\n",
       "     'adult onset diabetes',\n",
       "     'adult-onset diabetes',\n",
       "     'diabetes mellitis type 2',\n",
       "     'diabetes mellitis type II',\n",
       "     'diabetes, type 2',\n",
       "     'non-insulin dependent diabetes',\n",
       "     'non-insulin dependent diabetes mellitus',\n",
       "     'non-insulin-dependent diabetes mellitus',\n",
       "     'noninsulin dependent diabetes',\n",
       "     'T2DM - type 2 diabetes mellitus',\n",
       "     'type 2 diabetes',\n",
       "     'type 2 diabetes mellitus',\n",
       "     'type 2 diabetes mellitus non-insulin dependent',\n",
       "     'type II diabetes',\n",
       "     'type II diabetes mellitus'],\n",
       "    'name': 'type 2 diabetes mellitus',\n",
       "    'id': 'MONDO:0005148',\n",
       "    'equivalent_identifiers': ['MEDDRA:10012611',\n",
       "     'MEDDRA:10029402',\n",
       "     'EFO:0001360',\n",
       "     'MONDO:0005148',\n",
       "     'SNOMEDCT:44054006',\n",
       "     'DOID:9352',\n",
       "     'UMLS:CN244395',\n",
       "     'MEDDRA:10045242',\n",
       "     'NCIT:C26747',\n",
       "     'MESH:D003924',\n",
       "     'MEDDRA:10012612',\n",
       "     'MEDDRA:10026947',\n",
       "     'MEDDRA:10012613',\n",
       "     'MEDDRA:10067585',\n",
       "     'MedDRA:10067585',\n",
       "     'UMLS:C0011860',\n",
       "     'HP:0005978',\n",
       "     'MEDDRA:10029505'],\n",
       "    'type': ['named_thing', 'disease', 'disease_or_phenotypic_feature']},\n",
       "   {'iupac_name': '(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methyl-phenyl]-6-methylol-tetrahydropyran-3,4,5-triol;hydrate',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'VHOFTEAWFCUTOS-TUGBYPPCSA-N',\n",
       "    'role': True,\n",
       "    'smiles': 'Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1.Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1.O',\n",
       "    'mass': '907.04700',\n",
       "    'molecular_weight': 907,\n",
       "    'drug': True,\n",
       "    'biochemical_role': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'Cc1ccc(C2OC(CO)C(O)C(O)C2O)cc1Cc1ccc(-c2ccc(F)cc2)s1',\n",
       "    'chebi.orig_smiles': 'O.[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)c1ccc(C)c(Cc2ccc(s2)-c2ccc(F)cc2)c1.[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)c1ccc(C)c(Cc2ccc(s2)-c2ccc(F)cc2)c1',\n",
       "    'id': 'CHEBI:73272',\n",
       "    'molecular_formula': 'C48H52F2O11S2',\n",
       "    'pubchem.orig_smiles': 'CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F.CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F.O',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/2C24H25FO5S.H2O/c2*1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14;/h2*2-10,19,21-24,26-29H,11-12H2,1H3;1H2/t2*19-,21-,22+,23-,24+;/m11./s1',\n",
       "    'synonyms': ['(1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol--water (2/1)',\n",
       "     '(1S)-1,5-Anhydro-1-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-D-glucitol hemihydrate',\n",
       "     'canagliflozin',\n",
       "     'canagliflozin hemihydrate',\n",
       "     'Invokana',\n",
       "     'JNJ-28431754',\n",
       "     'TA-7284'],\n",
       "    'equivalent_identifiers': ['CHEMBL.COMPOUND:CHEMBL2103841',\n",
       "     'INCHIKEY:VHOFTEAWFCUTOS-TUGBYPPCSA-N',\n",
       "     'CHEBI:73272',\n",
       "     'PUBCHEM:24997615',\n",
       "     'MESH:D000068896',\n",
       "     'UNII:0SAC974Z85'],\n",
       "    'sodium_glucose_transport_protein_subtype_2_inhibitor': True,\n",
       "    'application': True,\n",
       "    'name': 'canagliflozin hydrate',\n",
       "    'monoisotopic_mass': '906.29191',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C22H26O6',\n",
       "    'iupac_name': \"(1S,3'R,4'S,5'S,6'R)-6-(4-ethylbenzyl)-6'-methylol-spiro[phthalan-1,2'-tetrahydropyran]-3',4',5'-triol\",\n",
       "    'pubchem.orig_smiles': 'CCC1=CC=C(C=C1)CC2=CC3=C(CO[C@@]34[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C2',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'VWVKUNOPTJGDOB-BDHVOXNPSA-N',\n",
       "    'inchi': 'InChI=1S/C22H26O6/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22+/m1/s1',\n",
       "    'drugbank.categories': ['Benzene Derivatives',\n",
       "     'Carbohydrates',\n",
       "     'Glycosides'],\n",
       "    'smiles': 'CCc1ccc(Cc2ccc3c(c2)[C@]2(OC3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1',\n",
       "    'synonyms': ['apleway', 'CSG452', 'deberza', 'tofogliflozin hydrate'],\n",
       "    'mass': '386.439',\n",
       "    'molecular_weight': 386.4,\n",
       "    'equivalent_identifiers': ['UNII:554245W62T',\n",
       "     'CHEBI:136041',\n",
       "     'DRUGBANK:DB11824',\n",
       "     'GTOPDB:9395',\n",
       "     'INCHIKEY:VWVKUNOPTJGDOB-BDHVOXNPSA-N',\n",
       "     'PUBCHEM:46908929',\n",
       "     'CHEMBL.COMPOUND:CHEMBL2110731'],\n",
       "    'simple_smiles': 'CCc1ccc(Cc2ccc3c(c2)C2(OC3)OC(CO)C(O)C(O)C2O)cc1',\n",
       "    'name': 'tofogliflozin',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'C=1C2=C(C=C(C1)CC3=CC=C(C=C3)CC)[C@]4(OC2)O[C@@H]([C@H]([C@@H]([C@H]4O)O)O)CO',\n",
       "    'monoisotopic_mass': '386.17294',\n",
       "    'id': 'CHEBI:136041',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide',\n",
       "    'pharmaceutical': True,\n",
       "    'role': True,\n",
       "    'inchikey': 'ZNNLBTZKUZBEKO-UHFFFAOYSA-N',\n",
       "    'smiles': 'COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1',\n",
       "    'drugbank.accession_number': 'APRD00233',\n",
       "    'mass': '494.00400',\n",
       "    'EC_2.7.1.*_(phosphotransferases_with_an_alcohol_group_as_acceptor)_inhibitor': True,\n",
       "    'molecular_weight': ['494.0035'],\n",
       "    'biochemical_role': True,\n",
       "    'drug': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1',\n",
       "    'EC_3.6.*_(hydrolases_acting_on_acid_anhydrides)_inhibitor': True,\n",
       "    'cardiovascular_drug': True,\n",
       "    'chebi.orig_smiles': 'COc1ccc(Cl)cc1C(=O)NCCc1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1',\n",
       "    'EC_2.*_(transferase)_inhibitor': True,\n",
       "    'id': 'CHEBI:5441',\n",
       "    'molecular_formula': ['C23H28ClN3O5S'],\n",
       "    'pubchem.orig_smiles': 'COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3',\n",
       "    'charge': '0',\n",
       "    'EC_3.6.3.*_(acid_anhydride_hydrolase_catalysing_transmembrane_movement_of_substances)_inhibitor': True,\n",
       "    'inchi': 'InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)',\n",
       "    'anti_arrhythmia_drug': True,\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'BCRP/ABCG2 Substrates',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'BSEP/ABCB11 Inhibitors',\n",
       "     'BSEP/ABCB11 Substrates',\n",
       "     'Cytochrome P-450 CYP2C9 Inhibitors',\n",
       "     'Cytochrome P-450 CYP2C9 Inhibitors (strength unknown)',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Cytochrome P-450 CYP3A Inhibitors',\n",
       "     'Cytochrome P-450 CYP3A Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Inhibitors',\n",
       "     'Cytochrome P-450 CYP3A4 Inhibitors (weak)',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates (strength unknown)',\n",
       "     'Cytochrome P-450 Enzyme Inhibitors',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'OAT1/SLC22A6 inhibitors',\n",
       "     'Oral Hypoglycemics',\n",
       "     'P-glycoprotein/ABCB1 Inhibitors',\n",
       "     'Sulfones',\n",
       "     'Sulfonylurea Compounds',\n",
       "     'Sulfonylureas',\n",
       "     'Sulfur Compounds',\n",
       "     'Urea'],\n",
       "    'synonyms': ['5-chloro-N-(2-{4-[N-(N-cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide',\n",
       "     'Glyburide',\n",
       "     '1-((p-(2-(5-chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea',\n",
       "     '1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea',\n",
       "     '5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide',\n",
       "     'Diabeta',\n",
       "     'glibenclamida',\n",
       "     'glibenclamide',\n",
       "     'glibenclamidum',\n",
       "     'Glynase',\n",
       "     'Micronase'],\n",
       "    'EC_2.7.1.33_(pantothenate_kinase)_inhibitor': True,\n",
       "    'EC_3.*_(hydrolase)_inhibitor': True,\n",
       "    'EC_2.7.*_(P_containing_group_transferase)_inhibitor': True,\n",
       "    'equivalent_identifiers': ['MESH:D005905',\n",
       "     'GTOPDB:2414',\n",
       "     'KEGG.COMPOUND:C07022',\n",
       "     'HMDB:HMDB0015151',\n",
       "     'DRUGBANK:DB01016',\n",
       "     'CHEMBL.COMPOUND:CHEMBL472',\n",
       "     'INCHIKEY:ZNNLBTZKUZBEKO-UHFFFAOYSA-N',\n",
       "     'CHEBI:5441',\n",
       "     'UNII:SX6K58TVWC',\n",
       "     'PUBCHEM:3488'],\n",
       "    'application': True,\n",
       "    'name': 'glyburide',\n",
       "    'enzyme_inhibitor': True,\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '493.14382',\n",
       "    'EC_3.6.3.49_(channel_conductance_controlling_ATPase)_inhibitor': True,\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'QGJUIPDUBHWZPV-SGTAVMJGSA-N',\n",
       "    'role': True,\n",
       "    'smiles': 'N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2',\n",
       "    'mass': '315.41000',\n",
       "    'molecular_weight': 315.4,\n",
       "    'EC_3.4.14.*_(dipeptidyl__and_tripeptidyl_peptidases)_inhibitor': True,\n",
       "    'drug': True,\n",
       "    'biochemical_role': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'N#CC1CC2CC2N1C(=O)C(N)C12CC3CC(CC(O)(C3)C1)C2',\n",
       "    'chebi.orig_smiles': '[H][C@]12C[C@@H](C#N)N(C(=O)[C@@H](N)C34CC5CC(CC(O)(C5)C3)C4)[C@@]1([H])C2',\n",
       "    'id': 'CHEBI:71272',\n",
       "    'molecular_formula': 'C18H25N3O2',\n",
       "    'pubchem.orig_smiles': 'C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10?,11?,12-,13+,14+,15-,17?,18?/m1/s1',\n",
       "    'drugbank.categories': ['Agents causing angioedema',\n",
       "     'Alimentary Tract and Metabolism',\n",
       "     'Amino Acids, Peptides, and Proteins',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cycloparaffins',\n",
       "     'Cytochrome P-450 CYP3A Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates (strength unknown)',\n",
       "     'Cytochrome P-450 CYP3A5 Substrates',\n",
       "     'DPP-IV Inhibitors',\n",
       "     'Drugs that are Mainly Renally Excreted',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Enzyme Inhibitors',\n",
       "     'Hormones',\n",
       "     'Hormones, Hormone Substitutes, and Hormone Antagonists',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'Incretins',\n",
       "     'OAT3/SLC22A8 Substrates',\n",
       "     'Oligopeptides',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Peptides',\n",
       "     'Protease Inhibitors'],\n",
       "    'synonyms': ['(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile',\n",
       "     '(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile',\n",
       "     'BMS 477118',\n",
       "     'BMS-477118',\n",
       "     'saxagliptin'],\n",
       "    'EC_3.*_(hydrolase)_inhibitor': True,\n",
       "    'EC_3.4.14.5_(dipeptidyl_peptidase_IV)_inhibitor': True,\n",
       "    'equivalent_identifiers': ['DRUGBANK:DB06335',\n",
       "     'PUBCHEM:11243969',\n",
       "     'CHEMBL.COMPOUND:CHEMBL385517',\n",
       "     'CHEBI:71272',\n",
       "     'HMDB:HMDB0015634',\n",
       "     'INCHIKEY:QGJUIPDUBHWZPV-SGTAVMJGSA-N',\n",
       "     'GTOPDB:6316'],\n",
       "    'application': True,\n",
       "    'EC_3.4.*_(hydrolases_acting_on_peptide_bond)_inhibitor': True,\n",
       "    'name': 'saxagliptin',\n",
       "    'enzyme_inhibitor': True,\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '315.19468',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '(2S,3R,4R,5S,6R)-2-[4-chloro-3-[4-[(3S)-tetrahydrofuran-3-yl]oxybenzyl]phenyl]-6-methylol-tetrahydropyran-3,4,5-triol',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'OBWASQILIWPZMG-QZMOQZSNSA-N',\n",
       "    'role': True,\n",
       "    'smiles': 'OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O',\n",
       "    'mass': '450.90900',\n",
       "    'molecular_weight': 450.9,\n",
       "    'drug': True,\n",
       "    'biochemical_role': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'OCC1OC(c2ccc(Cl)c(Cc3ccc(OC4CCOC4)cc3)c2)C(O)C(O)C1O',\n",
       "    'chebi.orig_smiles': 'OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(Cl)c(Cc2ccc(O[C@H]3CCOC3)cc2)c1',\n",
       "    'id': 'CHEBI:82720',\n",
       "    'molecular_formula': 'C23H27ClO7',\n",
       "    'pubchem.orig_smiles': 'C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2/t17-,19+,20+,21-,22+,23-/m0/s1',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Benzene Derivatives',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Carbohydrates',\n",
       "     'Diuretics',\n",
       "     'Drugs that are Mainly Renally Excreted',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Glycosides',\n",
       "     'Hypotensive Agents',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sodium-glucose co-transporter 2 (SGLT2) inhibitors',\n",
       "     'Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors',\n",
       "     'Sodium-Glucose Transporter 2 Inhibitors'],\n",
       "    'synonyms': ['(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol',\n",
       "     'empagliflozin',\n",
       "     '(1S)-1,5-anhydro-1-C-{4-chloro-3-((4-{((3S)-oxolan-3-yl)oxy}phenyl)methyl)phenyl}-D-glucitol',\n",
       "     '1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene',\n",
       "     'BI 10773',\n",
       "     'BI-10773',\n",
       "     'BI10773',\n",
       "     'JARDIANCE'],\n",
       "    'equivalent_identifiers': ['INCHIKEY:OBWASQILIWPZMG-QZMOQZSNSA-N',\n",
       "     'UNII:HDC1R2M35U',\n",
       "     'CHEBI:82720',\n",
       "     'MESH:C570240',\n",
       "     'DRUGBANK:DB09038',\n",
       "     'GTOPDB:4754',\n",
       "     'PUBCHEM:11949646',\n",
       "     'CHEMBL.COMPOUND:CHEMBL2107830'],\n",
       "    'sodium_glucose_transport_protein_subtype_2_inhibitor': True,\n",
       "    'application': True,\n",
       "    'name': 'empagliflozin',\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '450.14453',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C18H19F8N5O2',\n",
       "    'iupac_name': '1-[(2S)-2-amino-4-[2,4-bis(trifluoromethyl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-4-keto-butyl]-5,5-difluoro-2-piperidone',\n",
       "    'pubchem.orig_smiles': 'C1CC(CN(C1=O)C[C@H](CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C(F)(F)F)N)(F)F',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'ZWPRRQZNBDYKLH-VIFPVBQESA-N',\n",
       "    'inchi': 'InChI=1S/C18H19F8N5O2/c19-16(20)3-1-12(32)31(8-16)6-9(27)5-13(33)30-4-2-10-11(7-30)28-15(18(24,25)26)29-14(10)17(21,22)23/h9H,1-8,27H2/t9-/m0/s1',\n",
       "    'drugbank.categories': ['Agents causing angioedema',\n",
       "     'Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Diabetes Mellitus, Type 2, drug therapy',\n",
       "     'DPP-IV Inhibitors',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Piperidines'],\n",
       "    'smiles': 'N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1CC(F)(F)CCC1=O',\n",
       "    'synonyms': ['LC15-0444', 'zemiglo'],\n",
       "    'mass': '489.364',\n",
       "    'molecular_weight': 489.4,\n",
       "    'equivalent_identifiers': ['PUBCHEM:11953153',\n",
       "     'UNII:5DHU18M5D6',\n",
       "     'MESH:C534891',\n",
       "     'DRUGBANK:DB12412',\n",
       "     'CHEBI:134731',\n",
       "     'INCHIKEY:ZWPRRQZNBDYKLH-VIFPVBQESA-N',\n",
       "     'CHEMBL.COMPOUND:CHEMBL3707235'],\n",
       "    'simple_smiles': 'NC(CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1CC(F)(F)CCC1=O',\n",
       "    'name': 'gemigliptin',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'C(F)(F)(F)C1=C2C(CN(C(C[C@@H](CN3CC(F)(F)CCC3=O)N)=O)CC2)=NC(C(F)(F)F)=N1',\n",
       "    'monoisotopic_mass': '489.14110',\n",
       "    'id': 'CHEBI:134731',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C20H27N5O5S',\n",
       "    'iupac_name': 'N-[2-[4-(azepan-1-ylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-isoxazole-3-carboxamide',\n",
       "    'pubchem.orig_smiles': 'CC1=CC(=NO1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NN3CCCCCC3',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'ZKUDBRCEOBOWLF-UHFFFAOYSA-N',\n",
       "    'inchi': 'InChI=1S/C20H27N5O5S/c1-15-14-18(23-30-15)19(26)21-11-10-16-6-8-17(9-7-16)31(28,29)24-20(27)22-25-12-4-2-3-5-13-25/h6-9,14H,2-5,10-13H2,1H3,(H,21,26)(H2,22,24,27)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sulfones',\n",
       "     'Sulfonylureas',\n",
       "     'Sulfur Compounds',\n",
       "     'Urea'],\n",
       "    'smiles': 'Cc1cc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NN3CCCCCC3)cc2)no1',\n",
       "    'synonyms': ['glisepin', 'glisoxepid'],\n",
       "    'mass': '449.526',\n",
       "    'molecular_weight': 449.5,\n",
       "    'equivalent_identifiers': ['CHEMBL.COMPOUND:CHEMBL2106618',\n",
       "     'CHEBI:135731',\n",
       "     'INCHIKEY:ZKUDBRCEOBOWLF-UHFFFAOYSA-N',\n",
       "     'UNII:H7SC0I332I',\n",
       "     'HMDB:HMDB0015406',\n",
       "     'MESH:C100171',\n",
       "     'PUBCHEM:32778',\n",
       "     'DRUGBANK:DB01289'],\n",
       "    'simple_smiles': 'Cc1cc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NN3CCCCCC3)cc2)no1',\n",
       "    'name': 'glisoxepide',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'S(NC(NN1CCCCCC1)=O)(=O)(=O)C2=CC=C(C=C2)CCNC(=O)C3=NOC(=C3)C',\n",
       "    'monoisotopic_mass': '449.17329',\n",
       "    'id': 'CHEBI:135731',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C27H33N3O6S',\n",
       "    'iupac_name': '1-cyclohexyl-3-[4-[2-(1,3-diketo-7-methoxy-4,4-dimethyl-2-isoquinolyl)ethyl]phenyl]sulfonyl-urea',\n",
       "    'pubchem.orig_smiles': 'CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'LLJFMFZYVVLQKT-UHFFFAOYSA-N',\n",
       "    'inchi': 'InChI=1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sulfones',\n",
       "     'Sulfonylureas',\n",
       "     'Sulfur Compounds',\n",
       "     'Urea'],\n",
       "    'smiles': 'COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C',\n",
       "    'synonyms': ['beglynor',\n",
       "     'gliquidone calcium',\n",
       "     'gliquidone monosodium',\n",
       "     'gliquidone sodium',\n",
       "     'glurenorm'],\n",
       "    'mass': '527.635',\n",
       "    'molecular_weight': 527.6,\n",
       "    'equivalent_identifiers': ['HMDB:HMDB0015381',\n",
       "     'CHEMBL.COMPOUND:CHEMBL383634',\n",
       "     'MESH:C010969',\n",
       "     'UNII:C7C2QDD75P',\n",
       "     'DRUGBANK:DB01251',\n",
       "     'CHEBI:93416',\n",
       "     'INCHIKEY:LLJFMFZYVVLQKT-UHFFFAOYSA-N',\n",
       "     'PUBCHEM:91610'],\n",
       "    'simple_smiles': 'COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C',\n",
       "    'name': '1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-2-isoquinolinyl)ethyl]phenyl]sulfonylurea',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C',\n",
       "    'monoisotopic_mass': '527.20901',\n",
       "    'drugbank.approved': True,\n",
       "    'id': 'CHEBI:93416',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'pharmaceutical': True,\n",
       "    'inchikey': 'OELFLUMRDSZNSF-BRWVUGGUSA-N',\n",
       "    'role': True,\n",
       "    'drugbank.accession_number': 'APRD00593',\n",
       "    'smiles': 'CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1',\n",
       "    'mass': '317.42260',\n",
       "    'EC_3.4.14.*_(dipeptidyl__and_tripeptidyl_peptidases)_inhibitor': True,\n",
       "    'biochemical_role': True,\n",
       "    'drug': True,\n",
       "    'acid': True,\n",
       "    'donor': True,\n",
       "    'inhibitor': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'CC(C)C1CCC(C(=O)NC(Cc2ccccc2)C(=O)O)CC1',\n",
       "    'chebi.orig_smiles': 'CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](Cc1ccccc1)C(O)=O',\n",
       "    'id': 'CHEBI:31897',\n",
       "    'molecular_formula': 'C19H27NO3',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Amino Acids',\n",
       "     'Amino Acids, Aromatic',\n",
       "     'Amino Acids, Cyclic',\n",
       "     'Amino Acids, Essential',\n",
       "     'Amino Acids, Peptides, and Proteins',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cycloparaffins',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Cytochrome P-450 CYP2D6 Substrates',\n",
       "     'Cytochrome P-450 CYP3A Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates',\n",
       "     'Cytochrome P-450 CYP3A4 Substrates (strength unknown)',\n",
       "     'Cytochrome P-450 CYP3A5 Substrates',\n",
       "     'Cytochrome P-450 CYP3A7 Substrates',\n",
       "     'Drugs that are Mainly Renally Excreted',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Glinide',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'OAT1/SLC22A6 inhibitors',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Potassium Channel Antagonists',\n",
       "     'UGT1A9 Substrates'],\n",
       "    'synonyms': ['N-[(trans-4-isopropylcyclohexyl)carbonyl]-D-phenylalanine',\n",
       "     '(-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine',\n",
       "     'A 4166',\n",
       "     'A-4166',\n",
       "     'AY 4166',\n",
       "     'AY-4166',\n",
       "     'AY4166',\n",
       "     'Fastic',\n",
       "     'nateglinida',\n",
       "     'nateglinide',\n",
       "     'nateglinidum',\n",
       "     'Starlix',\n",
       "     'Starsis',\n",
       "     'trans-N-{[4-(1-methylethyl)cyclohexyl]carbonyl}-D-phenylalanine'],\n",
       "    'EC_3.*_(hydrolase)_inhibitor': True,\n",
       "    'EC_3.4.14.5_(dipeptidyl_peptidase_IV)_inhibitor': True,\n",
       "    'Bronsted_acid': True,\n",
       "    'equivalent_identifiers': ['INCHIKEY:OELFLUMRDSZNSF-BRWVUGGUSA-N',\n",
       "     'GTOPDB:6833',\n",
       "     'DRUGBANK:DB00731',\n",
       "     'CHEMBL.COMPOUND:CHEMBL783',\n",
       "     'UNII:41X3PWK4O2',\n",
       "     'CHEBI:31897',\n",
       "     'MESH:D000077715'],\n",
       "    'application': True,\n",
       "    'chemical_role': True,\n",
       "    'EC_3.4.*_(hydrolases_acting_on_peptide_bond)_inhibitor': True,\n",
       "    'name': 'nateglinide',\n",
       "    'drugbank.investigational': True,\n",
       "    'enzyme_inhibitor': True,\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '317.19909',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C11H17N3O3S',\n",
       "    'iupac_name': '1-butyl-3-sulfanilyl-urea',\n",
       "    'pubchem.orig_smiles': 'CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)N',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'VDTNNGKXZGSZIP-UHFFFAOYSA-N',\n",
       "    'inchi': 'InChI=1S/C11H17N3O3S/c1-2-3-8-13-11(15)14-18(16,17)10-6-4-9(12)5-7-10/h4-7H,2-3,8,12H2,1H3,(H2,13,14,15)',\n",
       "    'smiles': 'CCCCNC(=O)NS(=O)(=O)c1ccc(N)cc1',\n",
       "    'synonyms': ['aminophenurobutane',\n",
       "     'bucarban',\n",
       "     'burcol',\n",
       "     'butisulfina',\n",
       "     'butylcarbamide',\n",
       "     'carbutamid',\n",
       "     'glybutamide',\n",
       "     'nadisan',\n",
       "     'nadizan',\n",
       "     'norboral',\n",
       "     'sulfaninylbutylurea'],\n",
       "    'mass': '271.337',\n",
       "    'molecular_weight': 271.34,\n",
       "    'equivalent_identifiers': ['UNII:E3K8P4869P',\n",
       "     'CHEBI:135118',\n",
       "     'CHEMBL.COMPOUND:CHEMBL448570',\n",
       "     'MESH:D002271',\n",
       "     'PUBCHEM:9564',\n",
       "     'INCHIKEY:VDTNNGKXZGSZIP-UHFFFAOYSA-N'],\n",
       "    'simple_smiles': 'CCCCNC(=O)NS(=O)(=O)c1ccc(N)cc1',\n",
       "    'name': 'carbutamide',\n",
       "    'chebi.orig_smiles': 'CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1',\n",
       "    'monoisotopic_mass': '271.09906',\n",
       "    'id': 'CHEBI:135118',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '1-(4-acetylphenyl)sulfonyl-3-cyclohexyl-urea',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'VGZSUPCWNCWDAN-UHFFFAOYSA-N',\n",
       "    'role': True,\n",
       "    'drugbank.accession_number': 'APRD00773',\n",
       "    'smiles': 'CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1',\n",
       "    'mass': '324.39500',\n",
       "    'secretagogue': True,\n",
       "    'molecular_weight': ['324.3953'],\n",
       "    'drug': True,\n",
       "    'biochemical_role': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'CC(=O)c1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1',\n",
       "    'chebi.orig_smiles': 'CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC1CCCCC1',\n",
       "    'id': 'CHEBI:28052',\n",
       "    'insulin_secretagogue': True,\n",
       "    'molecular_formula': ['C15H20N2O4S'],\n",
       "    'pubchem.orig_smiles': 'CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sulfones',\n",
       "     'Sulfonylurea Compounds',\n",
       "     'Sulfonylureas',\n",
       "     'Sulfur Compounds',\n",
       "     'Urea'],\n",
       "    'synonyms': ['4-acetyl-N-(cyclohexylcarbamoyl)benzene-1-sulfonamide',\n",
       "     '1-((p-Acetylphenyl)sulfonyl)-3-cyclohexylurea',\n",
       "     '4-Acetyl-N-((cyclohexylamino)carbonyl)benzenesulfonamide',\n",
       "     'acetohexamida',\n",
       "     'acetohexamide',\n",
       "     'acetohexamidum',\n",
       "     'Dymelor',\n",
       "     \"N-(p-Acetylphenylsulfonyl)-N'-cyclohexylurea\"],\n",
       "    'equivalent_identifiers': ['CHEBI:28052',\n",
       "     'CHEMBL.COMPOUND:CHEMBL1589',\n",
       "     'PUBCHEM:1989',\n",
       "     'HMDB:HMDB0014558',\n",
       "     'KEGG.COMPOUND:C06806',\n",
       "     'UNII:QGC8W08I6I',\n",
       "     'GTOPDB:6793',\n",
       "     'INCHIKEY:VGZSUPCWNCWDAN-UHFFFAOYSA-N',\n",
       "     'MESH:D000092',\n",
       "     'DRUGBANK:DB00414'],\n",
       "    'application': True,\n",
       "    'drugbank.withdrawn': True,\n",
       "    'name': 'acetohexamide',\n",
       "    'drugbank.investigational': True,\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '324.11438',\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-tosyl-urea',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'BOVGTQGAOIONJV-UHFFFAOYSA-N',\n",
       "    'role': True,\n",
       "    'drugbank.accession_number': 'APRD00460',\n",
       "    'smiles': 'Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1',\n",
       "    'mass': '323.41100',\n",
       "    'secretagogue': True,\n",
       "    'molecular_weight': 323.4,\n",
       "    'drug': True,\n",
       "    'biochemical_role': True,\n",
       "    'hypoglycemic_agent': True,\n",
       "    'simple_smiles': 'Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1',\n",
       "    'chebi.orig_smiles': 'Cc1ccc(cc1)S(=O)(=O)NC(=O)NN1CC2CCCC2C1',\n",
       "    'id': 'CHEBI:31654',\n",
       "    'insulin_secretagogue': True,\n",
       "    'molecular_formula': 'C15H21N3O3S',\n",
       "    'pubchem.orig_smiles': 'CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2',\n",
       "    'antioxidant': True,\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Cytochrome P-450 CYP2C19 Inhibitors',\n",
       "     'Cytochrome P-450 CYP2C19 inhibitors (unknown strength)',\n",
       "     'Cytochrome P-450 CYP2C9 Substrates',\n",
       "     'Cytochrome P-450 Enzyme Inhibitors',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Hypoglycemia-Associated Agents',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sulfones',\n",
       "     'Sulfonylurea Compounds',\n",
       "     'Sulfonylureas',\n",
       "     'Sulfur Compounds',\n",
       "     'Urea'],\n",
       "    'synonyms': ['Gliclazide',\n",
       "     'N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide',\n",
       "     '1-(3-azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea',\n",
       "     '1-(hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea',\n",
       "     'Glimicron'],\n",
       "    'equivalent_identifiers': ['INCHIKEY:BOVGTQGAOIONJV-UHFFFAOYSA-N',\n",
       "     'CHEMBL.COMPOUND:CHEMBL427216',\n",
       "     'DRUGBANK:DB01120',\n",
       "     'CHEBI:31654',\n",
       "     'HMDB:HMDB0015252',\n",
       "     'PUBCHEM:3475'],\n",
       "    'application': True,\n",
       "    'chemical_role': True,\n",
       "    'name': 'gliclazide',\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '323.13036',\n",
       "    'radical_scavenger': True,\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C13H15N3O4S',\n",
       "    'iupac_name': 'N-[5-(2-methoxyethoxy)pyrimidin-2-yl]benzenesulfonamide',\n",
       "    'pubchem.orig_smiles': 'COCCOC1=CN=C(N=C1)NS(=O)(=O)C2=CC=CC=C2',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'QFWPJPIVLCBXFJ-UHFFFAOYSA-N',\n",
       "    'inchi': 'InChI=1S/C13H15N3O4S/c1-19-7-8-20-11-9-14-13(15-10-11)16-21(17,18)12-5-3-2-4-6-12/h2-6,9-10H,7-8H2,1H3,(H,14,15,16)',\n",
       "    'drugbank.categories': ['Alimentary Tract and Metabolism',\n",
       "     'Amides',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Genito Urinary System and Sex Hormones',\n",
       "     'Gynecological Antiinfectives and Antiseptics',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sulfonamides',\n",
       "     'Sulfones',\n",
       "     'Sulfur Compounds'],\n",
       "    'smiles': 'COCCOc1cnc(NS(=O)(=O)c2ccccc2)nc1',\n",
       "    'synonyms': ['glymidine sodium',\n",
       "     'Glymidine sodium',\n",
       "     'glidiazine',\n",
       "     'glycodiazine',\n",
       "     'glycodiazine sodium',\n",
       "     'gondafon'],\n",
       "    'mass': '309.342',\n",
       "    'molecular_weight': 309.34,\n",
       "    'equivalent_identifiers': ['HMDB:HMDB0015461',\n",
       "     'CHEBI:31660',\n",
       "     'DRUGBANK:DB01382',\n",
       "     'UNII:4C5I4BQZ8F',\n",
       "     'PUBCHEM:9565',\n",
       "     'CHEMBL.COMPOUND:CHEMBL1697838',\n",
       "     'MESH:C073263',\n",
       "     'INCHIKEY:QFWPJPIVLCBXFJ-UHFFFAOYSA-N'],\n",
       "    'simple_smiles': 'COCCOc1cnc(NS(=O)(=O)c2ccccc2)nc1',\n",
       "    'name': 'Glymidine sodium',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'S(NC=1N=CC(=CN1)OCCOC)(=O)(=O)C2=CC=CC=C2',\n",
       "    'drugbank.approved': True,\n",
       "    'monoisotopic_mass': '309.07833',\n",
       "    'id': 'CHEBI:31660',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'iupac_name': '(2S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-4-carboxy-butanoyl]amino]acetyl]amino]-3-hydroxy-butanoyl]amino]-3-phenyl-propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-carboxy-propanoyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-4-carboxy-butanoyl]amino]acetyl]amino]-5-keto-pentanoyl]amino]propanoyl]amino]propanoyl]amino]-6-[[(1S)-1-[[(1S)-1-benzyl-2-[[(1S,2S)-1-[[(1S)-2-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[2-[[(1S)-1-(carboxymethylcarbamoyl)-4-guanidino-butyl]amino]-2-keto-ethyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-2-methyl-propyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-keto-ethyl]amino]-2-keto-1-methyl-ethyl]carbamoyl]-2-methyl-butyl]amino]-2-keto-ethyl]carbamoyl]-3-carboxy-propyl]amino]-6-keto-hexyl]amino]-5-keto-2-palmitamido-valeric acid',\n",
       "    'pharmaceutical': True,\n",
       "    'inchikey': 'YSDQQAXHVYUZIW-QCIJIYAXSA-N',\n",
       "    'role': True,\n",
       "    'Bronsted_base': True,\n",
       "    'smiles': 'CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)C(=O)O',\n",
       "    'mass': '3751.20200',\n",
       "    'neuroprotective_agent': True,\n",
       "    'molecular_weight': 3751,\n",
       "    'drug': True,\n",
       "    'simple_smiles': 'CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(N)=O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(NC(=O)C(Cc1ccccc1)NC(=O)C(NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(N)Cc1cnc[nH]1)C(C)O)C(C)O)C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(Cc1ccccc1)C(=O)NC(C(=O)NC(C)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)C(C)C)C(C)CC)C(=O)O',\n",
       "    'chebi.orig_smiles': 'CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)C(O)=O',\n",
       "    'id': 'CHEBI:71193',\n",
       "    'protective_agent': True,\n",
       "    'pharmacological_role': True,\n",
       "    'molecular_formula': 'C172H265N43O51',\n",
       "    'pubchem.orig_smiles': 'CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N)C(=O)O',\n",
       "    'charge': '0',\n",
       "    'inchi': 'InChI=1S/C172H265N43O51/c1-18-20-21-22-23-24-25-26-27-28-29-30-37-53-129(224)195-116(170(265)266)59-64-128(223)180-68-41-40-50-111(153(248)199-115(62-67-135(232)233)154(249)204-120(73-100-44-33-31-34-45-100)159(254)214-140(93(11)19-2)167(262)192-97(15)146(241)201-122(76-103-79-183-108-49-39-38-48-106(103)108)157(252)203-118(72-90(5)6)158(253)212-138(91(7)8)165(260)200-110(52-43-70-182-172(177)178)149(244)184-81-130(225)193-109(51-42-69-181-171(175)176)148(243)187-84-137(236)237)196-144(239)95(13)189-143(238)94(12)191-152(247)114(58-63-127(174)222)194-131(226)82-185-151(246)113(61-66-134(230)231)198-155(250)117(71-89(3)4)202-156(251)119(75-102-54-56-105(221)57-55-102)205-162(257)124(85-216)208-164(259)126(87-218)209-166(261)139(92(9)10)213-161(256)123(78-136(234)235)206-163(258)125(86-217)210-169(264)142(99(17)220)215-160(255)121(74-101-46-35-32-36-47-101)207-168(263)141(98(16)219)211-132(227)83-186-150(245)112(60-65-133(228)229)197-145(240)96(14)190-147(242)107(173)77-104-80-179-88-188-104/h31-36,38-39,44-49,54-57,79-80,88-99,107,109-126,138-142,183,216-221H,18-30,37,40-43,50-53,58-78,81-87,173H2,1-17H3,(H2,174,222)(H,179,188)(H,180,223)(H,184,244)(H,185,246)(H,186,245)(H,187,243)(H,189,238)(H,190,242)(H,191,247)(H,192,262)(H,193,225)(H,194,226)(H,195,224)(H,196,239)(H,197,240)(H,198,250)(H,199,248)(H,200,260)(H,201,241)(H,202,251)(H,203,252)(H,204,249)(H,205,257)(H,206,258)(H,207,263)(H,208,259)(H,209,261)(H,210,264)(H,211,227)(H,212,253)(H,213,256)(H,214,254)(H,215,255)(H,228,229)(H,230,231)(H,232,233)(H,234,235)(H,236,237)(H,265,266)(H4,175,176,181)(H4,177,178,182)/t93-,94-,95-,96-,97-,98+,99+,107-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,138-,139-,140-,141-,142-/m0/s1',\n",
       "    'acceptor': True,\n",
       "    'synonyms': ['N2()-(L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl)-N(6)-(N-hexadecanoyl-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginylglycine',\n",
       "     'liraglutida',\n",
       "     'liraglutide',\n",
       "     'liraglutidum',\n",
       "     'NN 2211',\n",
       "     'NN-2211',\n",
       "     'NN2211',\n",
       "     'Victoza'],\n",
       "    'agonist': True,\n",
       "    'glucagon_like_peptide_1_receptor_agonist': True,\n",
       "    'equivalent_identifiers': ['PUBCHEM:16134956',\n",
       "     'MESH:D000069450',\n",
       "     'CHEMBL.COMPOUND:CHEMBL4084119',\n",
       "     'GTOPDB:1133',\n",
       "     'UNII:839I73S42A',\n",
       "     'INCHIKEY:YSDQQAXHVYUZIW-QCIJIYAXSA-N',\n",
       "     'CHEBI:71193'],\n",
       "    'application': True,\n",
       "    'chemical_role': True,\n",
       "    'name': 'liraglutide',\n",
       "    'monoisotopic_mass': '3748.94646',\n",
       "    'base': True,\n",
       "    'biological_role': True,\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C17H20F2N4O3S',\n",
       "    'iupac_name': '[(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-mesyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5-yl)tetrahydropyran-3-yl]amine',\n",
       "    'pubchem.orig_smiles': 'CS(=O)(=O)N1C=C2CN(CC2=N1)[C@@H]3C[C@@H]([C@H](OC3)C4=C(C=CC(=C4)F)F)N',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'MKMPWKUAHLTIBJ-ISTRZQFTSA-N',\n",
       "    'inchi': 'InChI=1S/C17H20F2N4O3S/c1-27(24,25)23-7-10-6-22(8-16(10)21-23)12-5-15(20)17(26-9-12)13-4-11(18)2-3-14(13)19/h2-4,7,12,15,17H,5-6,8-9,20H2,1H3/t12-,15+,17-/m1/s1',\n",
       "    'drugbank.categories': ['Agents causing angioedema',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'DPP-IV Inhibitors'],\n",
       "    'smiles': 'CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2',\n",
       "    'synonyms': ['marizev', 'Mk-3102', 'MK3102'],\n",
       "    'mass': '398.429',\n",
       "    'molecular_weight': 398.4,\n",
       "    'equivalent_identifiers': ['MESH:C587539',\n",
       "     'UNII:CVP59Q4JE1',\n",
       "     'INCHIKEY:MKMPWKUAHLTIBJ-ISTRZQFTSA-N',\n",
       "     'DRUGBANK:DB11992',\n",
       "     'CHEBI:134735',\n",
       "     'GTOPDB:8402',\n",
       "     'PUBCHEM:46209133',\n",
       "     'CHEMBL.COMPOUND:CHEMBL2105762'],\n",
       "    'simple_smiles': 'CS(=O)(=O)n1cc2c(n1)CN(C1COC(c3cc(F)ccc3F)C(N)C1)C2',\n",
       "    'name': 'omarigliptin',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'C1=C(C=CC(=C1[C@H]2OC[C@@H](C[C@@H]2N)N3CC=4C(C3)=NN(C4)S(C)(=O)=O)F)F',\n",
       "    'monoisotopic_mass': '398.12242',\n",
       "    'id': 'CHEBI:134735',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C10H21NO7',\n",
       "    'iupac_name': '(1S,2S,3R,4S,5S)-5-[(2-hydroxy-1-methylol-ethyl)amino]-1-methylol-cyclohexane-1,2,3,4-tetrol',\n",
       "    'pubchem.orig_smiles': 'C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)NC(CO)CO',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'FZNCGRZWXLXZSZ-CIQUZCHMSA-N',\n",
       "    'inchi': 'InChI=1S/C10H21NO7/c12-2-5(3-13)11-6-1-10(18,4-14)9(17)8(16)7(6)15/h5-9,11-18H,1-4H2/t6-,7-,8+,9-,10-/m0/s1',\n",
       "    'drugbank.categories': ['Alcohols',\n",
       "     'Alimentary Tract and Metabolism',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'Carbohydrates',\n",
       "     'Cyclohexanes',\n",
       "     'Cycloparaffins',\n",
       "     'Drugs Used in Diabetes',\n",
       "     'Enzyme Inhibitors',\n",
       "     'Fatty Alcohols',\n",
       "     'Glycoside Hydrolase Inhibitors',\n",
       "     'Hexanols',\n",
       "     'Lipids',\n",
       "     'Oral Hypoglycemics',\n",
       "     'Sugar Alcohols'],\n",
       "    'smiles': 'OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O',\n",
       "    'synonyms': ['Voglibose',\n",
       "     '3,4-Dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epi-inositol',\n",
       "     'AO-128',\n",
       "     'Basen (TN)',\n",
       "     'glustat',\n",
       "     'voglistat'],\n",
       "    'mass': '267.277',\n",
       "    'molecular_weight': 267.28,\n",
       "    'equivalent_identifiers': ['CHEBI:32300',\n",
       "     'UNII:S77P977AG8',\n",
       "     'MESH:C102817',\n",
       "     'CHEMBL.COMPOUND:CHEMBL476960',\n",
       "     'INCHIKEY:FZNCGRZWXLXZSZ-CIQUZCHMSA-N',\n",
       "     'HMDB:HMDB0015598',\n",
       "     'DRUGBANK:DB04878',\n",
       "     'PUBCHEM:444020'],\n",
       "    'simple_smiles': 'OCC(CO)NC1CC(O)(CO)C(O)C(O)C1O',\n",
       "    'name': 'Voglibose',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'N(C(CO)CO)[C@H]1C[C@@](CO)(O)[C@H]([C@@H]([C@H]1O)O)O',\n",
       "    'monoisotopic_mass': '267.13180',\n",
       "    'id': 'CHEBI:32300',\n",
       "    'type': ['named_thing', 'chemical_substance']},\n",
       "   {'molecular_formula': 'C19H25N7O2',\n",
       "    'iupac_name': 'N-[2-[[2-[(2S)-2-cyanopyrrolidino]-2-keto-ethyl]amino]-2-methyl-propyl]-2-methyl-pyrazolo[1,5-a]pyrimidine-6-carboxamide',\n",
       "    'pubchem.orig_smiles': 'CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N',\n",
       "    'charge': '0',\n",
       "    'inchikey': 'LDXYBEHACFJIEL-HNNXBMFYSA-N',\n",
       "    'inchi': 'InChI=1S/C19H25N7O2/c1-13-7-16-21-9-14(11-26(16)24-13)18(28)22-12-19(2,3)23-10-17(27)25-6-4-5-15(25)8-20/h7,9,11,15,23H,4-6,10,12H2,1-3H3,(H,22,28)/t15-/m0/s1',\n",
       "    'drugbank.categories': ['Agents causing angioedema',\n",
       "     'Blood Glucose Lowering Agents',\n",
       "     'DPP-IV Inhibitors'],\n",
       "    'smiles': 'Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1',\n",
       "    'synonyms': ['anagliptin HCl',\n",
       "     'anagliptin hydrochloride',\n",
       "     'beskoa',\n",
       "     'suiny'],\n",
       "    'mass': '383.448',\n",
       "    'molecular_weight': 383.4,\n",
       "    'equivalent_identifiers': ['MESH:C583175',\n",
       "     'DRUGBANK:DB12417',\n",
       "     'CHEMBL.COMPOUND:CHEMBL1929396',\n",
       "     'PUBCHEM:44513473',\n",
       "     'INCHIKEY:LDXYBEHACFJIEL-HNNXBMFYSA-N',\n",
       "     'UNII:K726J96838',\n",
       "     'CHEBI:136043'],\n",
       "    'simple_smiles': 'Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N)cn2n1',\n",
       "    'name': 'anagliptin',\n",
       "    'drugbank.investigational': True,\n",
       "    'chebi.orig_smiles': 'C1=C(C=NC=2N1N=C(C2)C)C(NCC(NCC(N3[C@@H](CCC3)C#N)=O)(C)C)=O',\n",
       "    'monoisotopic_mass': '383.20697',\n",
       "    'id': 'CHEBI:136043',\n",
       "    'type': ['named_thing', 'chemical_substance']}],\n",
       "  'edges': [{'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572487646.036501,\n",
       "    'id': '7da694bbccacb10421ea43adc902b172',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:134725',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572474582.191362,\n",
       "    'id': 'e918af17b16fb0f91bc8a46ad2ecb25f',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:135731',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_adverse_events',\n",
       "    'ctime': 1572493034.026079,\n",
       "    'id': '7b7d2245aeb2183efbc8b4749eae5e8b',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:82720',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_adverse_events',\n",
       "    'ctime': 1572495411.3236198,\n",
       "    'id': '47877372020c204be21b831c83b4854c',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:40237',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_adverse_events',\n",
       "    'ctime': 1572485453.4012928,\n",
       "    'id': 'd569acaeef6b86c245ce7427f55ca90e',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:5441',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_adverse_events',\n",
       "    'ctime': 1572495453.1631253,\n",
       "    'id': 'a432be57e752928ba8e8e35c1fffaf6a',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:5384',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572496119.2161326,\n",
       "    'id': '91e528335a4e68e031f405c5adeda9c8',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:32300',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572472876.4699764,\n",
       "    'id': 'e6ea1a1c5f55f6d061072c3bf66e2c87',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:3650',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572486756.1467369,\n",
       "    'id': 'e7d5b5fa7a3f7e167b08b75d2f54c99a',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:8805',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572485735.7566755,\n",
       "    'id': '7d4926c7a37ce6f2667eb3c0ce108857',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:27999',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572484754.1161103,\n",
       "    'id': '0cd51525ab6609fb980256c685b1c430',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:2376',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572493363.4955935,\n",
       "    'id': '6bfa51d92077ce9c2199cbd246c4fdeb',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:73274',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572500279.2517464,\n",
       "    'id': '1102029d8841bf0d7c8d2ef47209a14a',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:71272',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572472208.177294,\n",
       "    'id': '4f4ad284b25d1e2079f6f0cb39b2348b',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:136041',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572471211.685825,\n",
       "    'id': '5bc4788d14ac1d7fbee5ca8b6e6846ba',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:135285',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572487664.3343492,\n",
       "    'id': '3b11cb16521e673a49e4f6f96fd302a9',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:134735',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572490859.9585342,\n",
       "    'id': '9136d8ff414de9d94ab005b4c689615b',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:72323',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572495450.929644,\n",
       "    'id': 'e693021f9660437218c35212a02e3317',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:5383',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572485744.8485193,\n",
       "    'id': '81d25c03711d540423bd0a333bab2b8d',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:6801',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572464848.170774,\n",
       "    'id': 'e474d8315636847eed8b28df47bb5e75',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:135118',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_adverse_events',\n",
       "    'ctime': 1572493312.4803376,\n",
       "    'id': '15551720213af58c59255ba3c0723d07',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:73272',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572494016.9936101,\n",
       "    'id': 'ae473b7796d80274ae774e51cdaa0841',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:85078',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572487626.1693456,\n",
       "    'id': '0c69cdeb184a217e9993d669adf4e6d9',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:134715',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572467950.8625946,\n",
       "    'id': '6333f699b0aeea29493ceaff35365aba',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:135545',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572490852.4565017,\n",
       "    'id': '4d619257f8c148c470dba0811a7b699a',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:93416',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572495413.7685604,\n",
       "    'id': '623c0cb5e42c5892173ed3a7a85498ff',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:31897',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_adverse_events',\n",
       "    'ctime': 1572496074.7818449,\n",
       "    'id': 'b70221071b1b7f067c65c19ae2a5a743',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:68610',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572490918.603386,\n",
       "    'id': '44f3354fecc8a6e3ca6d33c44a34e26f',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:31654',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572472213.0732222,\n",
       "    'id': 'b59f6f77c9932889d9adf3c6c42caaf7',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:136042',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572472629.5796065,\n",
       "    'id': 'd7759261541a1e1abce9463a08b136d7',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:135349',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572484772.2938235,\n",
       "    'id': '16b4be0e2c99725cfb05436da8a81951',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:28052',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572487656.9810417,\n",
       "    'id': 'c24c1e06d201269d63c03a4ee44aa0a3',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:134731',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572482171.7573428,\n",
       "    'id': 'b7daa0996dde24c1acd04ca2fec6b992',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:136052',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572486764.7190425,\n",
       "    'id': 'ca7aac7ea5e26e766e749dd6047d0cb3',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:8228',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572493977.8362367,\n",
       "    'id': 'e1fa568bffad9c6e3997f6c2a7bafc04',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:71193',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572487644.1295896,\n",
       "    'id': 'a5eb2e56c412ca8c99d032d235f8ccb6',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:134724',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572490924.459634,\n",
       "    'id': '2cd8564e4600119ce684f274dfdc53a4',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:31660',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572486784.416829,\n",
       "    'id': '3f77dcc07f6db5d36e4a48ce3ec3be2e',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:6935',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572493518.6533782,\n",
       "    'id': 'f250222ce759cc501fc8db08a10ef129',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:9753',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572482130.1070402,\n",
       "    'id': '5c434a9f8d2aee118188d31154201208',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:136043',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572486763.2394958,\n",
       "    'id': '373496ec172b7dd9006aae33314163e8',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:3209',\n",
       "    'target_id': 'MONDO:0005148'},\n",
       "   {'predicate_id': 'RO:0002606',\n",
       "    'relation_label': 'treats',\n",
       "    'edge_source': 'mychem.get_drugcentral',\n",
       "    'ctime': 1572495942.84721,\n",
       "    'id': '8ba8f9b1cce29a5b4b5b92037c1fca3d',\n",
       "    'source_database': 'mychem',\n",
       "    'relation': 'RO:0002606',\n",
       "    'publications': [],\n",
       "    'type': 'treats',\n",
       "    'source_id': 'CHEBI:9613',\n",
       "    'target_id': 'MONDO:0005148'}]},\n",
       " 'results': []}"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "r.json()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "It took 0:00:00.216365 s to return\n"
     ]
    }
   ],
   "source": [
    "def create_proc_question(disease_curie, relation_type):\n",
    "    question = { \"nodes\": [{\"id\":\"n0\", \"type\":\"disease\", \"curie\":disease_curie},\n",
    "                          {\"id\": \"n1\", \"type\":\"biological_process_or_activity\"}],\n",
    "                 \"edges\": [ {\"id\": \"e0\", \"source_id\": \"n0\", \"target_id\": \"n1\", \"type\": relation_type}]}\n",
    "    return {'query_graph':question}\n",
    "\n",
    "disease = \"MONDO:0005148\"   #T2D\n",
    "edgetype=\"disrupts\"\n",
    "question = create_proc_question(disease,edgetype)\n",
    "res = query_automat(question,'uberon')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'query_graph': {'nodes': [{'id': 'n0',\n",
       "    'type': 'disease',\n",
       "    'curie': 'MONDO:0005148'},\n",
       "   {'id': 'n1', 'type': 'biological_process_or_activity'}],\n",
       "  'edges': [{'id': 'e0',\n",
       "    'source_id': 'n0',\n",
       "    'target_id': 'n1',\n",
       "    'type': 'disrupts'}]},\n",
       " 'results': [],\n",
       " 'knowledge_graph': {'nodes': [], 'edges': []}}"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "res"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
